<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:022ec572-7599-413f-a732-9bc2215e3ead,g:97b6b519-4d9b-420d-9c2f-d4e8a38933d1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CoverPage" xlink:type="simple" xlink:href="anab-20220331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f25cb4c6-8dc2-4038-83e3-4c65475d45cd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_DocumentType_f25cb4c6-8dc2-4038-83e3-4c65475d45cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_5d8e0b92-178c-44f8-a97f-e335f0226a95" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_DocumentQuarterlyReport_5d8e0b92-178c-44f8-a97f-e335f0226a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f73415dd-c5b6-450f-8378-a2b778cc5285" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_DocumentPeriodEndDate_f73415dd-c5b6-450f-8378-a2b778cc5285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_2cb2b2d2-3c87-48ae-842d-1e7764c86812" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_DocumentTransitionReport_2cb2b2d2-3c87-48ae-842d-1e7764c86812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a450cf27-deac-4752-aa2e-e6db695b07e0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntityFileNumber_a450cf27-deac-4752-aa2e-e6db695b07e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5e95afd1-a7bd-4876-80c3-213bc8622bc3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntityRegistrantName_5e95afd1-a7bd-4876-80c3-213bc8622bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0f9e5cb9-5ab7-488c-94c0-43ea7d3e64e2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0f9e5cb9-5ab7-488c-94c0-43ea7d3e64e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_01d391f2-386d-45ca-8b42-1221f66419f6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntityTaxIdentificationNumber_01d391f2-386d-45ca-8b42-1221f66419f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_95d7a70e-8cc5-4073-9b24-ba64267c2d92" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntityAddressAddressLine1_95d7a70e-8cc5-4073-9b24-ba64267c2d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_5b46ca15-f39d-4acb-870a-5532d3e634c9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntityAddressAddressLine2_5b46ca15-f39d-4acb-870a-5532d3e634c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_47bb16d0-b142-4a26-a8b7-6d77220cc349" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntityAddressCityOrTown_47bb16d0-b142-4a26-a8b7-6d77220cc349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_49191472-7598-46a7-a3a8-dcbeb50f9cce" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntityAddressStateOrProvince_49191472-7598-46a7-a3a8-dcbeb50f9cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4c1dfac6-c727-487d-a326-26a40b083ba6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntityAddressPostalZipCode_4c1dfac6-c727-487d-a326-26a40b083ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_021b3879-f648-4a50-8b4a-12e28b6cd890" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_CityAreaCode_021b3879-f648-4a50-8b4a-12e28b6cd890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_96bf8f27-b899-4c8b-821b-cf7f06057ef6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_LocalPhoneNumber_96bf8f27-b899-4c8b-821b-cf7f06057ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_7ae91e11-f9d2-45d6-85dd-46de208d5aa9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_Security12bTitle_7ae91e11-f9d2-45d6-85dd-46de208d5aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_19521f1d-0426-4a03-8ba0-631e9c6f15d6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_TradingSymbol_19521f1d-0426-4a03-8ba0-631e9c6f15d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_468d95a9-f7b4-4c52-b5c9-a5be57d9f56a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_SecurityExchangeName_468d95a9-f7b4-4c52-b5c9-a5be57d9f56a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_4f732e7d-f6cc-43f7-9126-3dffcac34218" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntityCurrentReportingStatus_4f732e7d-f6cc-43f7-9126-3dffcac34218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e694db71-0cdb-4cbd-b5eb-9bf4241b413d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntityInteractiveDataCurrent_e694db71-0cdb-4cbd-b5eb-9bf4241b413d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_8f8016ca-bcf0-40ef-b35a-84b2d07a7eeb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntityFilerCategory_8f8016ca-bcf0-40ef-b35a-84b2d07a7eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6a3d2907-fe24-4109-a3a3-806a66daeff8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntitySmallBusiness_6a3d2907-fe24-4109-a3a3-806a66daeff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_42528f1d-c90e-41d5-bb22-9eb569ce32a2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntityEmergingGrowthCompany_42528f1d-c90e-41d5-bb22-9eb569ce32a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_b9d649aa-d670-4066-b019-b6a49919b986" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntityShellCompany_b9d649aa-d670-4066-b019-b6a49919b986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_41ce8975-c580-414b-a72a-7dc805107925" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_41ce8975-c580-414b-a72a-7dc805107925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4f12fbcc-62ee-4225-bb34-4ace2812f493" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_EntityCentralIndexKey_4f12fbcc-62ee-4225-bb34-4ace2812f493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_d901a6e2-0fe9-4d23-91eb-121e92fd1f38" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_CurrentFiscalYearEndDate_d901a6e2-0fe9-4d23-91eb-121e92fd1f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_279a8c0b-a325-4f8e-a37e-2467391e3109" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_DocumentFiscalYearFocus_279a8c0b-a325-4f8e-a37e-2467391e3109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_677c3690-ab5f-4b9a-ba8f-bb158fbd89d9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_DocumentFiscalPeriodFocus_677c3690-ab5f-4b9a-ba8f-bb158fbd89d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9fb6fe41-0ba6-403a-8505-2e811d474e72" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7152d7f6-1055-4a32-b18a-dae3f90706fc" xlink:to="loc_dei_AmendmentFlag_9fb6fe41-0ba6-403a-8505-2e811d474e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="anab-20220331.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_49c93a50-ccf6-4938-8ce6-39098e3ee3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_391195de-2d40-48b6-ab59-5829d934e215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_49c93a50-ccf6-4938-8ce6-39098e3ee3a0" xlink:to="loc_us-gaap_AssetsAbstract_391195de-2d40-48b6-ab59-5829d934e215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_0cbc0fe9-22f2-4b1e-ba7b-138d69d46b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_391195de-2d40-48b6-ab59-5829d934e215" xlink:to="loc_us-gaap_AssetsCurrentAbstract_0cbc0fe9-22f2-4b1e-ba7b-138d69d46b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f5e44600-3194-4b17-a17f-c1387c6adf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0cbc0fe9-22f2-4b1e-ba7b-138d69d46b6a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f5e44600-3194-4b17-a17f-c1387c6adf1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_96799b7c-09f3-4c91-85ae-fe4a947142f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0cbc0fe9-22f2-4b1e-ba7b-138d69d46b6a" xlink:to="loc_us-gaap_ReceivablesNetCurrent_96799b7c-09f3-4c91-85ae-fe4a947142f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_bd97f233-2c36-40e0-9876-90ad7b8d5351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0cbc0fe9-22f2-4b1e-ba7b-138d69d46b6a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_bd97f233-2c36-40e0-9876-90ad7b8d5351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5da2463b-a6b3-4804-a04f-17f4a89d77b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0cbc0fe9-22f2-4b1e-ba7b-138d69d46b6a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5da2463b-a6b3-4804-a04f-17f4a89d77b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3f208bb7-b2e9-490f-808c-1fb07bc816d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0cbc0fe9-22f2-4b1e-ba7b-138d69d46b6a" xlink:to="loc_us-gaap_AssetsCurrent_3f208bb7-b2e9-490f-808c-1fb07bc816d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a179ec2f-0fc3-47ee-bf9e-4dfa95cb3571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_391195de-2d40-48b6-ab59-5829d934e215" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a179ec2f-0fc3-47ee-bf9e-4dfa95cb3571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e275f8f8-9047-4e1b-a416-e59514088b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_391195de-2d40-48b6-ab59-5829d934e215" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e275f8f8-9047-4e1b-a416-e59514088b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_662307bd-10ae-46d8-ae4f-db63778965a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_391195de-2d40-48b6-ab59-5829d934e215" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_662307bd-10ae-46d8-ae4f-db63778965a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ddd8de35-fe02-4634-a566-4e2d4a748294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_391195de-2d40-48b6-ab59-5829d934e215" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ddd8de35-fe02-4634-a566-4e2d4a748294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3e168c6e-95f3-4cdb-b2b1-48c9c7976b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_391195de-2d40-48b6-ab59-5829d934e215" xlink:to="loc_us-gaap_Assets_3e168c6e-95f3-4cdb-b2b1-48c9c7976b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_076c1055-32f7-4c62-96e6-b6df6d614ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_49c93a50-ccf6-4938-8ce6-39098e3ee3a0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_076c1055-32f7-4c62-96e6-b6df6d614ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_a3439b09-c4de-4514-b700-06096204dbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_076c1055-32f7-4c62-96e6-b6df6d614ff4" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_a3439b09-c4de-4514-b700-06096204dbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_de230ec1-8a74-490c-bda7-090b1fe5f603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a3439b09-c4de-4514-b700-06096204dbb8" xlink:to="loc_us-gaap_AccountsPayableCurrent_de230ec1-8a74-490c-bda7-090b1fe5f603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_95bec643-4415-4b90-9987-685f3687754e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a3439b09-c4de-4514-b700-06096204dbb8" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_95bec643-4415-4b90-9987-685f3687754e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d7d5a68d-1b2a-48a4-a39f-8f252965ac48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a3439b09-c4de-4514-b700-06096204dbb8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d7d5a68d-1b2a-48a4-a39f-8f252965ac48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_dcdb06ce-a809-425b-8f57-8fd0cbba9bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a3439b09-c4de-4514-b700-06096204dbb8" xlink:to="loc_us-gaap_LiabilitiesCurrent_dcdb06ce-a809-425b-8f57-8fd0cbba9bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AdvanceFutureRoyaltiesLiabilityNoncurrent_493918d7-d4b7-456c-ad5b-c7608a27df0f" xlink:href="anab-20220331.xsd#anab_AdvanceFutureRoyaltiesLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_076c1055-32f7-4c62-96e6-b6df6d614ff4" xlink:to="loc_anab_AdvanceFutureRoyaltiesLiabilityNoncurrent_493918d7-d4b7-456c-ad5b-c7608a27df0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_404744a9-d4a9-49c3-8945-a7e2e5f0b952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_076c1055-32f7-4c62-96e6-b6df6d614ff4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_404744a9-d4a9-49c3-8945-a7e2e5f0b952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_f0e35f9d-4e05-4ba1-b361-8aa030c3e262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_076c1055-32f7-4c62-96e6-b6df6d614ff4" xlink:to="loc_us-gaap_StockholdersEquityAbstract_f0e35f9d-4e05-4ba1-b361-8aa030c3e262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_aaca4abb-183d-41d1-8206-d6ed1051248b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f0e35f9d-4e05-4ba1-b361-8aa030c3e262" xlink:to="loc_us-gaap_PreferredStockValue_aaca4abb-183d-41d1-8206-d6ed1051248b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6b2cd560-531d-4895-b348-d5a9c57799ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f0e35f9d-4e05-4ba1-b361-8aa030c3e262" xlink:to="loc_us-gaap_CommonStockValue_6b2cd560-531d-4895-b348-d5a9c57799ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_0672d870-6343-4208-94a8-4a4aba0cd9f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f0e35f9d-4e05-4ba1-b361-8aa030c3e262" xlink:to="loc_us-gaap_AdditionalPaidInCapital_0672d870-6343-4208-94a8-4a4aba0cd9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_698c6412-2085-44da-a925-ecd96889925f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f0e35f9d-4e05-4ba1-b361-8aa030c3e262" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_698c6412-2085-44da-a925-ecd96889925f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b85e7f83-80a4-4cce-8fd7-af605968ab6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f0e35f9d-4e05-4ba1-b361-8aa030c3e262" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b85e7f83-80a4-4cce-8fd7-af605968ab6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_65ad3f17-457d-4bfa-a561-be3e9296753d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f0e35f9d-4e05-4ba1-b361-8aa030c3e262" xlink:to="loc_us-gaap_StockholdersEquity_65ad3f17-457d-4bfa-a561-be3e9296753d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_947f2155-10d3-411d-ad6d-f859ecd1e4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_076c1055-32f7-4c62-96e6-b6df6d614ff4" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_947f2155-10d3-411d-ad6d-f859ecd1e4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="anab-20220331.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6f58bed0-04dc-4da3-8334-723e7ede66a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_3a5442a1-4ee3-4efa-8127-f72728e84f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f58bed0-04dc-4da3-8334-723e7ede66a5" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_3a5442a1-4ee3-4efa-8127-f72728e84f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_5481f546-c6f3-4666-b7eb-baf6593b1cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f58bed0-04dc-4da3-8334-723e7ede66a5" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_5481f546-c6f3-4666-b7eb-baf6593b1cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_5bbf6c9d-14d4-4e1e-bb01-b87647f63712" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f58bed0-04dc-4da3-8334-723e7ede66a5" xlink:to="loc_us-gaap_PreferredStockSharesIssued_5bbf6c9d-14d4-4e1e-bb01-b87647f63712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_a3fe57e1-25a8-465d-bb07-3814d0b1069e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f58bed0-04dc-4da3-8334-723e7ede66a5" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_a3fe57e1-25a8-465d-bb07-3814d0b1069e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b673ab07-456a-4052-b5c0-21346c6794ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f58bed0-04dc-4da3-8334-723e7ede66a5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b673ab07-456a-4052-b5c0-21346c6794ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1350b1d6-6ad2-428b-95ae-a798feba8d08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f58bed0-04dc-4da3-8334-723e7ede66a5" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1350b1d6-6ad2-428b-95ae-a798feba8d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_523c832e-a44d-4da6-8787-e5e7f717e0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f58bed0-04dc-4da3-8334-723e7ede66a5" xlink:to="loc_us-gaap_CommonStockSharesIssued_523c832e-a44d-4da6-8787-e5e7f717e0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f5510032-2139-46d7-b85e-8475c9f17239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f58bed0-04dc-4da3-8334-723e7ede66a5" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f5510032-2139-46d7-b85e-8475c9f17239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="anab-20220331.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_cc0659db-fee5-4a60-a671-d6470740af70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8246f977-6384-450f-9792-baacca236bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cc0659db-fee5-4a60-a671-d6470740af70" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8246f977-6384-450f-9792-baacca236bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_eaa1215b-393d-4bc4-9a63-68853fcac549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cc0659db-fee5-4a60-a671-d6470740af70" xlink:to="loc_us-gaap_OperatingExpensesAbstract_eaa1215b-393d-4bc4-9a63-68853fcac549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_de7e0713-d867-4bc5-a6d8-ac5cbc8c6597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eaa1215b-393d-4bc4-9a63-68853fcac549" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_de7e0713-d867-4bc5-a6d8-ac5cbc8c6597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_6f51789c-1aa3-4d53-beb4-b03eea34455a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eaa1215b-393d-4bc4-9a63-68853fcac549" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_6f51789c-1aa3-4d53-beb4-b03eea34455a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_227a0a51-1c23-4eed-8a93-c2b9e2770c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eaa1215b-393d-4bc4-9a63-68853fcac549" xlink:to="loc_us-gaap_OperatingExpenses_227a0a51-1c23-4eed-8a93-c2b9e2770c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_162e3c0f-cddb-488a-84af-efdb43ff8012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cc0659db-fee5-4a60-a671-d6470740af70" xlink:to="loc_us-gaap_OperatingIncomeLoss_162e3c0f-cddb-488a-84af-efdb43ff8012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e93d86be-669e-444c-a070-eff9e2348959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cc0659db-fee5-4a60-a671-d6470740af70" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e93d86be-669e-444c-a070-eff9e2348959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_d5f9a9c7-bb27-4444-9fb4-461d954bd028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeOther"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e93d86be-669e-444c-a070-eff9e2348959" xlink:to="loc_us-gaap_InterestIncomeOther_d5f9a9c7-bb27-4444-9fb4-461d954bd028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_NoncashAdvanceFutureRoyaltiesInterestExpense_fedef8ca-9e1f-493c-966b-ea26feef7fcc" xlink:href="anab-20220331.xsd#anab_NoncashAdvanceFutureRoyaltiesInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e93d86be-669e-444c-a070-eff9e2348959" xlink:to="loc_anab_NoncashAdvanceFutureRoyaltiesInterestExpense_fedef8ca-9e1f-493c-966b-ea26feef7fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_87604782-7441-4ac7-896a-e736f13e319a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e93d86be-669e-444c-a070-eff9e2348959" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_87604782-7441-4ac7-896a-e736f13e319a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_446909c8-bc12-4280-9bc3-15afd22bef76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e93d86be-669e-444c-a070-eff9e2348959" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_446909c8-bc12-4280-9bc3-15afd22bef76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e8b835e5-aa5f-40dc-a6f5-80b4e180eb66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cc0659db-fee5-4a60-a671-d6470740af70" xlink:to="loc_us-gaap_NetIncomeLoss_e8b835e5-aa5f-40dc-a6f5-80b4e180eb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_30e330ef-3236-4637-9d12-93bc44c88260" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cc0659db-fee5-4a60-a671-d6470740af70" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_30e330ef-3236-4637-9d12-93bc44c88260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f2a9c359-15d5-4e6d-99e3-e2ff66382e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cc0659db-fee5-4a60-a671-d6470740af70" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_f2a9c359-15d5-4e6d-99e3-e2ff66382e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_26318052-3be0-41d0-b448-5c5821fd5a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cc0659db-fee5-4a60-a671-d6470740af70" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_26318052-3be0-41d0-b448-5c5821fd5a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0b5060a1-e968-4d7e-a173-f16b5c20413e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_26318052-3be0-41d0-b448-5c5821fd5a4f" xlink:to="loc_us-gaap_EarningsPerShareBasic_0b5060a1-e968-4d7e-a173-f16b5c20413e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_84351e1a-6b91-47b9-a368-f8d72da2747f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_26318052-3be0-41d0-b448-5c5821fd5a4f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_84351e1a-6b91-47b9-a368-f8d72da2747f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_84b0afa8-e5f4-47eb-85ad-822c42cde7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cc0659db-fee5-4a60-a671-d6470740af70" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_84b0afa8-e5f4-47eb-85ad-822c42cde7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ff083364-879a-4b8f-9933-79f069ab5324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_84b0afa8-e5f4-47eb-85ad-822c42cde7a6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ff083364-879a-4b8f-9933-79f069ab5324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7a15325a-d3ec-4756-92d9-f31ab1d11bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_84b0afa8-e5f4-47eb-85ad-822c42cde7a6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7a15325a-d3ec-4756-92d9-f31ab1d11bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/ConsolidatedStatementsofOperationsandComprehensiveLossparenthetical" xlink:type="simple" xlink:href="anab-20220331.xsd#ConsolidatedStatementsofOperationsandComprehensiveLossparenthetical"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/ConsolidatedStatementsofOperationsandComprehensiveLossparenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_22a87390-01e2-4513-98ea-9d34095f96f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_f98ebf18-27aa-4802-8dde-839a52ca0303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_22a87390-01e2-4513-98ea-9d34095f96f0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_f98ebf18-27aa-4802-8dde-839a52ca0303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/ConsolidatedStatementofStockholdersEquity" xlink:type="simple" xlink:href="anab-20220331.xsd#ConsolidatedStatementofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/ConsolidatedStatementofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_00e68a98-b4a2-4d91-ba20-9c3676883959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_eb3e9069-1be2-42f7-9b42-a81b250ebbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_00e68a98-b4a2-4d91-ba20-9c3676883959" xlink:to="loc_us-gaap_StatementTable_eb3e9069-1be2-42f7-9b42-a81b250ebbe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6b40b341-273f-4c23-8cc7-6fce08cc3c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_eb3e9069-1be2-42f7-9b42-a81b250ebbe2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6b40b341-273f-4c23-8cc7-6fce08cc3c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_96996bc4-c1a1-4ef4-aa42-776cd2a1149c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6b40b341-273f-4c23-8cc7-6fce08cc3c17" xlink:to="loc_us-gaap_EquityComponentDomain_96996bc4-c1a1-4ef4-aa42-776cd2a1149c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f2bdf856-bade-4345-adb2-2e1d4c56e633" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_96996bc4-c1a1-4ef4-aa42-776cd2a1149c" xlink:to="loc_us-gaap_CommonStockMember_f2bdf856-bade-4345-adb2-2e1d4c56e633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7a7e16ed-ce17-4a9c-940a-8419352f776b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_96996bc4-c1a1-4ef4-aa42-776cd2a1149c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7a7e16ed-ce17-4a9c-940a-8419352f776b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0d8f75b0-d944-41b5-b90b-2cafe7cef9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_96996bc4-c1a1-4ef4-aa42-776cd2a1149c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0d8f75b0-d944-41b5-b90b-2cafe7cef9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_387079f4-7daf-4abd-8708-0421255df513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_96996bc4-c1a1-4ef4-aa42-776cd2a1149c" xlink:to="loc_us-gaap_RetainedEarningsMember_387079f4-7daf-4abd-8708-0421255df513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a42e0fee-9659-4d94-951c-602110e09a27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_eb3e9069-1be2-42f7-9b42-a81b250ebbe2" xlink:to="loc_us-gaap_StatementLineItems_a42e0fee-9659-4d94-951c-602110e09a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5fde1364-ce5b-4669-b40a-08226c2332b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a42e0fee-9659-4d94-951c-602110e09a27" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5fde1364-ce5b-4669-b40a-08226c2332b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_468fa385-37dd-415d-92c3-362fccac9df1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5fde1364-ce5b-4669-b40a-08226c2332b3" xlink:to="loc_us-gaap_SharesOutstanding_468fa385-37dd-415d-92c3-362fccac9df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c8c6f94c-abfd-40a8-9e60-5073d296d86d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5fde1364-ce5b-4669-b40a-08226c2332b3" xlink:to="loc_us-gaap_StockholdersEquity_c8c6f94c-abfd-40a8-9e60-5073d296d86d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEmployeeStockPurchasePlan_5a36bd78-e18f-4b00-b0a8-159dc2b16f64" xlink:href="anab-20220331.xsd#anab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEmployeeStockPurchasePlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5fde1364-ce5b-4669-b40a-08226c2332b3" xlink:to="loc_anab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEmployeeStockPurchasePlan_5a36bd78-e18f-4b00-b0a8-159dc2b16f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_StockIssuedDuringPeriodValueOptionsAndEmployeeStockPurchasePlan_eeae248b-c403-4bae-9fec-1a57c60b439b" xlink:href="anab-20220331.xsd#anab_StockIssuedDuringPeriodValueOptionsAndEmployeeStockPurchasePlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5fde1364-ce5b-4669-b40a-08226c2332b3" xlink:to="loc_anab_StockIssuedDuringPeriodValueOptionsAndEmployeeStockPurchasePlan_eeae248b-c403-4bae-9fec-1a57c60b439b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d6b74967-7c5e-42a5-9ee6-51ba42d87f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5fde1364-ce5b-4669-b40a-08226c2332b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d6b74967-7c5e-42a5-9ee6-51ba42d87f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e2dc4445-0f1c-49ae-8cac-34e8ec2a498e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5fde1364-ce5b-4669-b40a-08226c2332b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e2dc4445-0f1c-49ae-8cac-34e8ec2a498e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_187007f5-747e-4bd8-8d76-37e0dda3c94b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5fde1364-ce5b-4669-b40a-08226c2332b3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_187007f5-747e-4bd8-8d76-37e0dda3c94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2dbab96f-4036-4b38-a4ad-444f297bbcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5fde1364-ce5b-4669-b40a-08226c2332b3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2dbab96f-4036-4b38-a4ad-444f297bbcc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_91b47b20-0b37-463c-94c0-250cf0b1ed5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5fde1364-ce5b-4669-b40a-08226c2332b3" xlink:to="loc_us-gaap_NetIncomeLoss_91b47b20-0b37-463c-94c0-250cf0b1ed5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_1bdd9750-e35d-42dc-a40a-747283f9d10d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5fde1364-ce5b-4669-b40a-08226c2332b3" xlink:to="loc_us-gaap_SharesOutstanding_1bdd9750-e35d-42dc-a40a-747283f9d10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b7ea4d10-9d83-47f7-a4af-d161606283ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5fde1364-ce5b-4669-b40a-08226c2332b3" xlink:to="loc_us-gaap_StockholdersEquity_b7ea4d10-9d83-47f7-a4af-d161606283ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="anab-20220331.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1cae3ec3-2382-4169-bc4c-bcbae9c8cff5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_54587792-2a73-4bd6-a642-99691e375fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1cae3ec3-2382-4169-bc4c-bcbae9c8cff5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_54587792-2a73-4bd6-a642-99691e375fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_795da6d8-7335-40ca-af9e-f2ad368b8ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_54587792-2a73-4bd6-a642-99691e375fc9" xlink:to="loc_us-gaap_NetIncomeLoss_795da6d8-7335-40ca-af9e-f2ad368b8ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_99beaf50-19cf-40ed-a8e3-b9a81b7e08e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_54587792-2a73-4bd6-a642-99691e375fc9" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_99beaf50-19cf-40ed-a8e3-b9a81b7e08e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_cfa4ff86-d3fc-4c60-9382-14522e3fb888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_99beaf50-19cf-40ed-a8e3-b9a81b7e08e2" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_cfa4ff86-d3fc-4c60-9382-14522e3fb888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8301d94e-a76e-4d7e-a8eb-d0ee00aad9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_99beaf50-19cf-40ed-a8e3-b9a81b7e08e2" xlink:to="loc_us-gaap_ShareBasedCompensation_8301d94e-a76e-4d7e-a8eb-d0ee00aad9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_d11c8d6b-7465-4d6e-bead-586e24ea5614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_99beaf50-19cf-40ed-a8e3-b9a81b7e08e2" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_d11c8d6b-7465-4d6e-bead-586e24ea5614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_01596954-e3d8-46f4-affe-c6072a3958bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_99beaf50-19cf-40ed-a8e3-b9a81b7e08e2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_01596954-e3d8-46f4-affe-c6072a3958bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_b47b0c23-d226-4860-9455-2a0c9e7694a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_99beaf50-19cf-40ed-a8e3-b9a81b7e08e2" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_b47b0c23-d226-4860-9455-2a0c9e7694a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_be691223-9089-4e08-80f5-0e15fdcde0db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_99beaf50-19cf-40ed-a8e3-b9a81b7e08e2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_be691223-9089-4e08-80f5-0e15fdcde0db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_858726b6-e58d-4867-bc75-c2a9eab4cf41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_be691223-9089-4e08-80f5-0e15fdcde0db" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_858726b6-e58d-4867-bc75-c2a9eab4cf41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e9fd1098-3e83-4915-9d90-e7dbf60e02c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_be691223-9089-4e08-80f5-0e15fdcde0db" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e9fd1098-3e83-4915-9d90-e7dbf60e02c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3d9eb95c-c850-4a88-9998-5d517dc7f5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_be691223-9089-4e08-80f5-0e15fdcde0db" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3d9eb95c-c850-4a88-9998-5d517dc7f5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_82714732-fd2d-4362-9176-b02938118087" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_be691223-9089-4e08-80f5-0e15fdcde0db" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_82714732-fd2d-4362-9176-b02938118087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be0859b2-6550-47c2-b78a-3811a5118d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_54587792-2a73-4bd6-a642-99691e375fc9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be0859b2-6550-47c2-b78a-3811a5118d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f802eb8e-c343-4be0-91e1-292c8d5eb8c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1cae3ec3-2382-4169-bc4c-bcbae9c8cff5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f802eb8e-c343-4be0-91e1-292c8d5eb8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_8d87faaf-90da-4986-b516-232e66794369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f802eb8e-c343-4be0-91e1-292c8d5eb8c6" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_8d87faaf-90da-4986-b516-232e66794369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_93d06fb2-af67-4acf-904f-69888699b9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f802eb8e-c343-4be0-91e1-292c8d5eb8c6" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_93d06fb2-af67-4acf-904f-69888699b9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2ac73711-09fd-4d77-a43d-39c39283cfae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f802eb8e-c343-4be0-91e1-292c8d5eb8c6" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2ac73711-09fd-4d77-a43d-39c39283cfae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7da5f07c-1b13-43d4-9ca5-11fbc160d9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f802eb8e-c343-4be0-91e1-292c8d5eb8c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7da5f07c-1b13-43d4-9ca5-11fbc160d9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecdfbfb8-a16d-4395-a9a0-b29ea2e6b661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1cae3ec3-2382-4169-bc4c-bcbae9c8cff5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecdfbfb8-a16d-4395-a9a0-b29ea2e6b661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_876542ea-c847-4828-9a91-f31d116c9490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecdfbfb8-a16d-4395-a9a0-b29ea2e6b661" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_876542ea-c847-4828-9a91-f31d116c9490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AdvanceFutureRoyaltiesPayments_f20a98fc-5e3d-4da0-aa3d-4497bbff8841" xlink:href="anab-20220331.xsd#anab_AdvanceFutureRoyaltiesPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecdfbfb8-a16d-4395-a9a0-b29ea2e6b661" xlink:to="loc_anab_AdvanceFutureRoyaltiesPayments_f20a98fc-5e3d-4da0-aa3d-4497bbff8841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_946d8592-516d-4b92-a7be-0be9be521b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecdfbfb8-a16d-4395-a9a0-b29ea2e6b661" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_946d8592-516d-4b92-a7be-0be9be521b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0e0a2916-94f9-47cb-9f76-474fae5323ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecdfbfb8-a16d-4395-a9a0-b29ea2e6b661" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0e0a2916-94f9-47cb-9f76-474fae5323ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1eee56de-ea94-4148-834e-0a5e8a1ca207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1cae3ec3-2382-4169-bc4c-bcbae9c8cff5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1eee56de-ea94-4148-834e-0a5e8a1ca207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25cc061c-5eba-46f1-beed-9e233a09d346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1cae3ec3-2382-4169-bc4c-bcbae9c8cff5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25cc061c-5eba-46f1-beed-9e233a09d346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eee21b1c-638f-434b-9f19-98b89218e937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1cae3ec3-2382-4169-bc4c-bcbae9c8cff5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eee21b1c-638f-434b-9f19-98b89218e937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_5f9a0a33-866e-47d2-b4f4-3d1274fc50fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1cae3ec3-2382-4169-bc4c-bcbae9c8cff5" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_5f9a0a33-866e-47d2-b4f4-3d1274fc50fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0c551677-37b7-4cd0-8718-706346d6a1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5f9a0a33-866e-47d2-b4f4-3d1274fc50fd" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0c551677-37b7-4cd0-8718-706346d6a1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_NoncashAdvanceFutureRoyaltiesIssuanceCostsIncurredButNotYetPaid_0f39b162-828c-4853-8b36-aa8c3a3e637a" xlink:href="anab-20220331.xsd#anab_NoncashAdvanceFutureRoyaltiesIssuanceCostsIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0c551677-37b7-4cd0-8718-706346d6a1e1" xlink:to="loc_anab_NoncashAdvanceFutureRoyaltiesIssuanceCostsIncurredButNotYetPaid_0f39b162-828c-4853-8b36-aa8c3a3e637a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_86e70393-b2ec-4c8f-a523-f140db814f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0c551677-37b7-4cd0-8718-706346d6a1e1" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_86e70393-b2ec-4c8f-a523-f140db814f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/DescriptionoftheBusiness" xlink:type="simple" xlink:href="anab-20220331.xsd#DescriptionoftheBusiness"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/DescriptionoftheBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dea64ed7-d02f-4dc5-9f9a-dbc764d80133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_29b654f7-0ee4-4dfe-b828-1a1d6917c56d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dea64ed7-d02f-4dc5-9f9a-dbc764d80133" xlink:to="loc_us-gaap_NatureOfOperations_29b654f7-0ee4-4dfe-b828-1a1d6917c56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="anab-20220331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_603b3b33-d567-4dcc-8238-e2b69402336a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1d12a782-7f26-4c68-a41f-48c0894cd38e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b3b33-d567-4dcc-8238-e2b69402336a" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1d12a782-7f26-4c68-a41f-48c0894cd38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="anab-20220331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8c153210-f636-420b-bc5c-6d618da5f426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4b97e8cf-128f-4c43-ba9e-581e44c7ef09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c153210-f636-420b-bc5c-6d618da5f426" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4b97e8cf-128f-4c43-ba9e-581e44c7ef09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_eda32cfb-6ed7-4330-8667-b0db8174ab02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c153210-f636-420b-bc5c-6d618da5f426" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_eda32cfb-6ed7-4330-8667-b0db8174ab02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_aee9eb10-5bd9-4362-9fec-0590d4c91d71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c153210-f636-420b-bc5c-6d618da5f426" xlink:to="loc_us-gaap_UseOfEstimates_aee9eb10-5bd9-4362-9fec-0590d4c91d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_5e1b1639-32bd-42c5-9657-5d4b9e464573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c153210-f636-420b-bc5c-6d618da5f426" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_5e1b1639-32bd-42c5-9657-5d4b9e464573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="anab-20220331.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ac92d978-dcee-4569-b1ba-6882b35fd338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_7222d1a8-6d11-4c5c-a219-e982f8eb98c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac92d978-dcee-4569-b1ba-6882b35fd338" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_7222d1a8-6d11-4c5c-a219-e982f8eb98c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0bd0da08-2fa8-4449-9be6-dfc8d7aed690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_bcb063da-7e05-4dad-a5d3-d8a3e5221679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0bd0da08-2fa8-4449-9be6-dfc8d7aed690" xlink:to="loc_us-gaap_NumberOfReportableSegments_bcb063da-7e05-4dad-a5d3-d8a3e5221679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPoliciesSummaryofPotentiallyDilutiveSecuritiesDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#SummaryofSignificantAccountingPoliciesSummaryofPotentiallyDilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPoliciesSummaryofPotentiallyDilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e87d191f-ce88-4283-8086-0ae4599af176" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_4083cc99-da15-414d-976c-855c73f9ebeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e87d191f-ce88-4283-8086-0ae4599af176" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_4083cc99-da15-414d-976c-855c73f9ebeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_502a0094-42db-48c9-a783-ee13b1ab4fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_4083cc99-da15-414d-976c-855c73f9ebeb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_502a0094-42db-48c9-a783-ee13b1ab4fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4662adc0-74ac-4b23-9eff-ad31397c26be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_502a0094-42db-48c9-a783-ee13b1ab4fd9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4662adc0-74ac-4b23-9eff-ad31397c26be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0cc674fb-3e4e-4d10-b0be-3dde6727bc4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4662adc0-74ac-4b23-9eff-ad31397c26be" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0cc674fb-3e4e-4d10-b0be-3dde6727bc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7d0db507-fc5f-4489-a59a-1361767dc231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_4083cc99-da15-414d-976c-855c73f9ebeb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7d0db507-fc5f-4489-a59a-1361767dc231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e0fcc169-5dfa-4b2b-a35a-b85344a353e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7d0db507-fc5f-4489-a59a-1361767dc231" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e0fcc169-5dfa-4b2b-a35a-b85344a353e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/BalanceSheetAccountsandSupplementalDisclosures" xlink:type="simple" xlink:href="anab-20220331.xsd#BalanceSheetAccountsandSupplementalDisclosures"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/BalanceSheetAccountsandSupplementalDisclosures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0bfd2dc0-4fb1-4dee-b82c-96a7a7915fef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_99fb543d-f93c-4c91-a61b-f7e5aede1753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0bfd2dc0-4fb1-4dee-b82c-96a7a7915fef" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_99fb543d-f93c-4c91-a61b-f7e5aede1753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresTables" xlink:type="simple" xlink:href="anab-20220331.xsd#BalanceSheetAccountsandSupplementalDisclosuresTables"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_cb5787e9-cc0b-4171-8a10-11b0b2e666a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_8eca2967-96c5-4ce0-8273-983f50d5715b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_cb5787e9-cc0b-4171-8a10-11b0b2e666a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_8eca2967-96c5-4ce0-8273-983f50d5715b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_4206effc-3292-4c67-8b5b-b02623258bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_cb5787e9-cc0b-4171-8a10-11b0b2e666a5" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_4206effc-3292-4c67-8b5b-b02623258bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresPropertyandEquipmentnetDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#BalanceSheetAccountsandSupplementalDisclosuresPropertyandEquipmentnetDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresPropertyandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_60766565-6d13-4f05-b318-652e25ae7b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_025045ea-5757-41ec-9234-952beb6d2601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_60766565-6d13-4f05-b318-652e25ae7b65" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_025045ea-5757-41ec-9234-952beb6d2601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_24cc0df0-e266-4e9e-a417-bc4bd3a47ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_025045ea-5757-41ec-9234-952beb6d2601" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_24cc0df0-e266-4e9e-a417-bc4bd3a47ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3a379efc-4c67-41e5-aefe-20eb6bbc673d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_24cc0df0-e266-4e9e-a417-bc4bd3a47ce9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3a379efc-4c67-41e5-aefe-20eb6bbc673d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_LaboratoryEquipmentMember_7fba22d6-511c-4217-8123-ddf86e81742d" xlink:href="anab-20220331.xsd#anab_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3a379efc-4c67-41e5-aefe-20eb6bbc673d" xlink:to="loc_anab_LaboratoryEquipmentMember_7fba22d6-511c-4217-8123-ddf86e81742d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_bf5fd41b-b88f-4b9c-9890-919c03455fed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3a379efc-4c67-41e5-aefe-20eb6bbc673d" xlink:to="loc_us-gaap_OfficeEquipmentMember_bf5fd41b-b88f-4b9c-9890-919c03455fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_866e6581-b64b-4a15-8592-87de69032e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3a379efc-4c67-41e5-aefe-20eb6bbc673d" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_866e6581-b64b-4a15-8592-87de69032e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a622abcb-86c1-4643-a37f-674f1128526a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_025045ea-5757-41ec-9234-952beb6d2601" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a622abcb-86c1-4643-a37f-674f1128526a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_61ab2d6e-4e01-477a-969c-07b3c55d82a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a622abcb-86c1-4643-a37f-674f1128526a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_61ab2d6e-4e01-477a-969c-07b3c55d82a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a01e2bc8-d5af-4435-a854-cb443615ebfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a622abcb-86c1-4643-a37f-674f1128526a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a01e2bc8-d5af-4435-a854-cb443615ebfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4af05a2c-3467-4a06-a8d0-622ace07e8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a622abcb-86c1-4643-a37f-674f1128526a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4af05a2c-3467-4a06-a8d0-622ace07e8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresAccruedExpensesDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#BalanceSheetAccountsandSupplementalDisclosuresAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_5d536870-632b-4486-acee-0a3d142ec0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_95573578-921e-4126-ae59-e47606aeebb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_5d536870-632b-4486-acee-0a3d142ec0ac" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_95573578-921e-4126-ae59-e47606aeebb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_373aa32a-1431-4dba-9821-734e72c2e016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_5d536870-632b-4486-acee-0a3d142ec0ac" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_373aa32a-1431-4dba-9821-734e72c2e016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AccruedResearchAndDevelopmentExpensesCurrent_fb6628df-3ce7-4d65-844b-732858b1f7bd" xlink:href="anab-20220331.xsd#anab_AccruedResearchAndDevelopmentExpensesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_5d536870-632b-4486-acee-0a3d142ec0ac" xlink:to="loc_anab_AccruedResearchAndDevelopmentExpensesCurrent_fb6628df-3ce7-4d65-844b-732858b1f7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f5f8198a-47a9-434c-b881-4c66c46cf6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_5d536870-632b-4486-acee-0a3d142ec0ac" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f5f8198a-47a9-434c-b881-4c66c46cf6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_0b32bd7b-afe3-4300-b78a-0f0a41a3f0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_5d536870-632b-4486-acee-0a3d142ec0ac" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_0b32bd7b-afe3-4300-b78a-0f0a41a3f0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CollaborativeResearchandDevelopmentAgreements" xlink:type="simple" xlink:href="anab-20220331.xsd#CollaborativeResearchandDevelopmentAgreements"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/CollaborativeResearchandDevelopmentAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_b56f8257-c9fa-44b8-b617-de981bc69e75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_f7b349cb-c933-416f-9227-38baa6469898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_b56f8257-c9fa-44b8-b617-de981bc69e75" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_f7b349cb-c933-416f-9227-38baa6469898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CollaborativeResearchandDevelopmentAgreementsTables" xlink:type="simple" xlink:href="anab-20220331.xsd#CollaborativeResearchandDevelopmentAgreementsTables"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/CollaborativeResearchandDevelopmentAgreementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_34cdf57d-2c89-4df4-9470-769405f01102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_9173eab9-eb5a-4dfb-9aea-6b67911da46c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_34cdf57d-2c89-4df4-9470-769405f01102" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_9173eab9-eb5a-4dfb-9aea-6b67911da46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CollaborativeResearchandDevelopmentAgreementsNarrativeDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#CollaborativeResearchandDevelopmentAgreementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/CollaborativeResearchandDevelopmentAgreementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_1abd081f-0e88-48f1-9d6a-1561b3fa3a66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementByTypeTable_d69cb72a-07e6-4cbc-a92e-ff61ca38817a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueArrangementByTypeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_1abd081f-0e88-48f1-9d6a-1561b3fa3a66" xlink:to="loc_us-gaap_DeferredRevenueArrangementByTypeTable_d69cb72a-07e6-4cbc-a92e-ff61ca38817a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b94f32b8-ccdc-4017-a009-2d2e2b0f266a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_d69cb72a-07e6-4cbc-a92e-ff61ca38817a" xlink:to="loc_srt_CounterpartyNameAxis_b94f32b8-ccdc-4017-a009-2d2e2b0f266a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a3c36680-b4af-4268-8e19-49ab2cac6b03" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_b94f32b8-ccdc-4017-a009-2d2e2b0f266a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a3c36680-b4af-4268-8e19-49ab2cac6b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_GlaxoSmithKlineMember_ff51a134-bb36-4048-b1af-cb54396e6cb4" xlink:href="anab-20220331.xsd#anab_GlaxoSmithKlineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a3c36680-b4af-4268-8e19-49ab2cac6b03" xlink:to="loc_anab_GlaxoSmithKlineMember_ff51a134-bb36-4048-b1af-cb54396e6cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_BristolMyersSquibbMember_883d2152-20d8-4177-aa5b-ca80dd7ce8a4" xlink:href="anab-20220331.xsd#anab_BristolMyersSquibbMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a3c36680-b4af-4268-8e19-49ab2cac6b03" xlink:to="loc_anab_BristolMyersSquibbMember_883d2152-20d8-4177-aa5b-ca80dd7ce8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_396c41e4-32fb-4a08-a41c-2cd157e3cae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_d69cb72a-07e6-4cbc-a92e-ff61ca38817a" xlink:to="loc_us-gaap_TypeOfArrangementAxis_396c41e4-32fb-4a08-a41c-2cd157e3cae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_81c2f327-ce46-465c-9153-3405ed957c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_396c41e4-32fb-4a08-a41c-2cd157e3cae5" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_81c2f327-ce46-465c-9153-3405ed957c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_fcfa56f6-5afa-4218-8baf-ca1565c23865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_81c2f327-ce46-465c-9153-3405ed957c41" xlink:to="loc_us-gaap_CollaborativeArrangementMember_fcfa56f6-5afa-4218-8baf-ca1565c23865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_CollaborationAndExclusiveLicenseAgreementMember_e1c659af-9d35-485a-bbc0-07279ad7f78e" xlink:href="anab-20220331.xsd#anab_CollaborationAndExclusiveLicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementMember_fcfa56f6-5afa-4218-8baf-ca1565c23865" xlink:to="loc_anab_CollaborationAndExclusiveLicenseAgreementMember_e1c659af-9d35-485a-bbc0-07279ad7f78e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RoyaltyAgreementMember_c58dba8e-3ca0-47ba-9b82-0bfacacab1fd" xlink:href="anab-20220331.xsd#anab_RoyaltyAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementMember_fcfa56f6-5afa-4218-8baf-ca1565c23865" xlink:to="loc_anab_RoyaltyAgreementMember_c58dba8e-3ca0-47ba-9b82-0bfacacab1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RoyaltyAgreementUpTo10BillionMember_7ca8043d-861e-46c2-b143-44b9beb79661" xlink:href="anab-20220331.xsd#anab_RoyaltyAgreementUpTo10BillionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_RoyaltyAgreementMember_c58dba8e-3ca0-47ba-9b82-0bfacacab1fd" xlink:to="loc_anab_RoyaltyAgreementUpTo10BillionMember_7ca8043d-861e-46c2-b143-44b9beb79661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RoyaltyAgreementAbove10BillionMember_e508f096-cc99-436f-83f8-eb3d273545f4" xlink:href="anab-20220331.xsd#anab_RoyaltyAgreementAbove10BillionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_RoyaltyAgreementMember_c58dba8e-3ca0-47ba-9b82-0bfacacab1fd" xlink:to="loc_anab_RoyaltyAgreementAbove10BillionMember_e508f096-cc99-436f-83f8-eb3d273545f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RoyaltyPurchaseAgreementMember_e73a6bdd-8408-4d33-a575-5139fd90f301" xlink:href="anab-20220331.xsd#anab_RoyaltyPurchaseAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_81c2f327-ce46-465c-9153-3405ed957c41" xlink:to="loc_anab_RoyaltyPurchaseAgreementMember_e73a6bdd-8408-4d33-a575-5139fd90f301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5898e9c2-7a2f-42de-a4cc-b9a23a36ede0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_d69cb72a-07e6-4cbc-a92e-ff61ca38817a" xlink:to="loc_srt_ProductOrServiceAxis_5898e9c2-7a2f-42de-a4cc-b9a23a36ede0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_47b6d50d-fbf8-421b-b070-255400e897bd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5898e9c2-7a2f-42de-a4cc-b9a23a36ede0" xlink:to="loc_srt_ProductsAndServicesDomain_47b6d50d-fbf8-421b-b070-255400e897bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AnaptysBioGeneratedAntiPD1JEMPERLIDostarlimabMember_ecbebe78-b285-40da-a207-d0dd91851466" xlink:href="anab-20220331.xsd#anab_AnaptysBioGeneratedAntiPD1JEMPERLIDostarlimabMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_47b6d50d-fbf8-421b-b070-255400e897bd" xlink:to="loc_anab_AnaptysBioGeneratedAntiPD1JEMPERLIDostarlimabMember_ecbebe78-b285-40da-a207-d0dd91851466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_ZejulaMember_46baee0c-19e7-479f-9a5d-fde0b1286f88" xlink:href="anab-20220331.xsd#anab_ZejulaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_47b6d50d-fbf8-421b-b070-255400e897bd" xlink:to="loc_anab_ZejulaMember_46baee0c-19e7-479f-9a5d-fde0b1286f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AnaptysBioGeneratedAntiPD1AntagonistAntibodyCC90006Member_4be40bf4-cb88-49fb-877a-941da8de0862" xlink:href="anab-20220331.xsd#anab_AnaptysBioGeneratedAntiPD1AntagonistAntibodyCC90006Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_47b6d50d-fbf8-421b-b070-255400e897bd" xlink:to="loc_anab_AnaptysBioGeneratedAntiPD1AntagonistAntibodyCC90006Member_4be40bf4-cb88-49fb-877a-941da8de0862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_ZejulaAndAnaptysBioGeneratedJEMPERLIMember_8faba698-e5ad-4774-acce-52e01ae00986" xlink:href="anab-20220331.xsd#anab_ZejulaAndAnaptysBioGeneratedJEMPERLIMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_47b6d50d-fbf8-421b-b070-255400e897bd" xlink:to="loc_anab_ZejulaAndAnaptysBioGeneratedJEMPERLIMember_8faba698-e5ad-4774-acce-52e01ae00986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6e609d62-cfe1-4f6d-a275-fc2d8e6a31c5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_d69cb72a-07e6-4cbc-a92e-ff61ca38817a" xlink:to="loc_srt_RangeAxis_6e609d62-cfe1-4f6d-a275-fc2d8e6a31c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7b30e566-0cd8-4fa4-bb59-1383d709c53d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6e609d62-cfe1-4f6d-a275-fc2d8e6a31c5" xlink:to="loc_srt_RangeMember_7b30e566-0cd8-4fa4-bb59-1383d709c53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dad6990b-3fe3-4b0b-a8cf-eb4bffdd8be4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7b30e566-0cd8-4fa4-bb59-1383d709c53d" xlink:to="loc_srt_MinimumMember_dad6990b-3fe3-4b0b-a8cf-eb4bffdd8be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_70b9f5b8-2811-4736-8e59-d56b47e65893" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7b30e566-0cd8-4fa4-bb59-1383d709c53d" xlink:to="loc_srt_MaximumMember_70b9f5b8-2811-4736-8e59-d56b47e65893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementLineItems_34892fa0-df6a-41e8-acb0-4e8468fc1fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueArrangementLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_d69cb72a-07e6-4cbc-a92e-ff61ca38817a" xlink:to="loc_us-gaap_DeferredRevenueArrangementLineItems_34892fa0-df6a-41e8-acb0-4e8468fc1fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RevenueRecognitionMultipledeliverableArrangementsUpfrontFeeReceived_35434ac1-6e77-4aa8-9790-42b972c0debc" xlink:href="anab-20220331.xsd#anab_RevenueRecognitionMultipledeliverableArrangementsUpfrontFeeReceived"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_34892fa0-df6a-41e8-acb0-4e8468fc1fbc" xlink:to="loc_anab_RevenueRecognitionMultipledeliverableArrangementsUpfrontFeeReceived_35434ac1-6e77-4aa8-9790-42b972c0debc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RevenueRecognitionMilestoneMethodNumberOfOutstandingResearchAndDevelopmentTargets_d0217ced-068d-4daa-add6-993b58ced966" xlink:href="anab-20220331.xsd#anab_RevenueRecognitionMilestoneMethodNumberOfOutstandingResearchAndDevelopmentTargets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_34892fa0-df6a-41e8-acb0-4e8468fc1fbc" xlink:to="loc_anab_RevenueRecognitionMilestoneMethodNumberOfOutstandingResearchAndDevelopmentTargets_d0217ced-068d-4daa-add6-993b58ced966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RevenueRecognitionMilestoneMethodContingentUponPreClinicalRegulatoryAndCommercialEvents_239e4939-43dc-4dbc-84af-a761a297cd54" xlink:href="anab-20220331.xsd#anab_RevenueRecognitionMilestoneMethodContingentUponPreClinicalRegulatoryAndCommercialEvents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_34892fa0-df6a-41e8-acb0-4e8468fc1fbc" xlink:to="loc_anab_RevenueRecognitionMilestoneMethodContingentUponPreClinicalRegulatoryAndCommercialEvents_239e4939-43dc-4dbc-84af-a761a297cd54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RevenueRecognitionMilestoneMethodContingentUponCertainUnitedStatesAndEuropeanRegulatorySubmissionsAndApprovals_c85db6a7-4e5f-44a6-83d9-d3e990d281cd" xlink:href="anab-20220331.xsd#anab_RevenueRecognitionMilestoneMethodContingentUponCertainUnitedStatesAndEuropeanRegulatorySubmissionsAndApprovals"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_34892fa0-df6a-41e8-acb0-4e8468fc1fbc" xlink:to="loc_anab_RevenueRecognitionMilestoneMethodContingentUponCertainUnitedStatesAndEuropeanRegulatorySubmissionsAndApprovals_c85db6a7-4e5f-44a6-83d9-d3e990d281cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RevenueRecognitionMilestoneMethodContingentUponAchievementOfSpecifiedLevelsOfWorldwideSales_0b6f4c4c-44f3-4787-be99-d11bb43f2e7c" xlink:href="anab-20220331.xsd#anab_RevenueRecognitionMilestoneMethodContingentUponAchievementOfSpecifiedLevelsOfWorldwideSales"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_34892fa0-df6a-41e8-acb0-4e8468fc1fbc" xlink:to="loc_anab_RevenueRecognitionMilestoneMethodContingentUponAchievementOfSpecifiedLevelsOfWorldwideSales_0b6f4c4c-44f3-4787-be99-d11bb43f2e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_NetSalesRoyaltyPercent_781bb542-77bd-447e-b6de-d50806ed38f0" xlink:href="anab-20220331.xsd#anab_NetSalesRoyaltyPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_34892fa0-df6a-41e8-acb0-4e8468fc1fbc" xlink:to="loc_anab_NetSalesRoyaltyPercent_781bb542-77bd-447e-b6de-d50806ed38f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RevenueRecognitionMilestoneMethodAgreementTermFollowingFirstCommercialSaleOrExpirationOfTheLastToExpirePatent_ac65c366-8e15-4bfc-97b0-46814cf8f8f3" xlink:href="anab-20220331.xsd#anab_RevenueRecognitionMilestoneMethodAgreementTermFollowingFirstCommercialSaleOrExpirationOfTheLastToExpirePatent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_34892fa0-df6a-41e8-acb0-4e8468fc1fbc" xlink:to="loc_anab_RevenueRecognitionMilestoneMethodAgreementTermFollowingFirstCommercialSaleOrExpirationOfTheLastToExpirePatent_ac65c366-8e15-4bfc-97b0-46814cf8f8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_NetSalesRoyaltyThreshold_0a0f5685-8ffd-4195-a447-bcfce01c5790" xlink:href="anab-20220331.xsd#anab_NetSalesRoyaltyThreshold"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_34892fa0-df6a-41e8-acb0-4e8468fc1fbc" xlink:to="loc_anab_NetSalesRoyaltyThreshold_0a0f5685-8ffd-4195-a447-bcfce01c5790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RevenueRecognitionMultipleDeliverableArrangementsUpfrontFees_0825fcdb-642e-4cee-b4b9-eda07f4cb935" xlink:href="anab-20220331.xsd#anab_RevenueRecognitionMultipleDeliverableArrangementsUpfrontFees"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_34892fa0-df6a-41e8-acb0-4e8468fc1fbc" xlink:to="loc_anab_RevenueRecognitionMultipleDeliverableArrangementsUpfrontFees_0825fcdb-642e-4cee-b4b9-eda07f4cb935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RevenueRecognitionMilestoneMethodMilestonesAchievedDuringAmount_02821317-48b8-4764-b6eb-2d812978b1a1" xlink:href="anab-20220331.xsd#anab_RevenueRecognitionMilestoneMethodMilestonesAchievedDuringAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_34892fa0-df6a-41e8-acb0-4e8468fc1fbc" xlink:to="loc_anab_RevenueRecognitionMilestoneMethodMilestonesAchievedDuringAmount_02821317-48b8-4764-b6eb-2d812978b1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_269f96dd-6189-41e1-a353-8d84a6180848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_34892fa0-df6a-41e8-acb0-4e8468fc1fbc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_269f96dd-6189-41e1-a353-8d84a6180848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_NoncashAdvanceFutureRoyaltiesRevenue_9989a81f-a251-47b1-853e-dcc390151ada" xlink:href="anab-20220331.xsd#anab_NoncashAdvanceFutureRoyaltiesRevenue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_34892fa0-df6a-41e8-acb0-4e8468fc1fbc" xlink:to="loc_anab_NoncashAdvanceFutureRoyaltiesRevenue_9989a81f-a251-47b1-853e-dcc390151ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RevenueRecognitionMilestoneMethodNumberOfMilestonesAchievedDuringPeriod_0115d79b-e698-4fb5-b78a-75973987f936" xlink:href="anab-20220331.xsd#anab_RevenueRecognitionMilestoneMethodNumberOfMilestonesAchievedDuringPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_34892fa0-df6a-41e8-acb0-4e8468fc1fbc" xlink:to="loc_anab_RevenueRecognitionMilestoneMethodNumberOfMilestonesAchievedDuringPeriod_0115d79b-e698-4fb5-b78a-75973987f936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RevenueRecognitionMilestoneMethodMaximumRevenuePerMilestone_1034ddb2-9019-4e62-929e-4ab839bc26a8" xlink:href="anab-20220331.xsd#anab_RevenueRecognitionMilestoneMethodMaximumRevenuePerMilestone"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_34892fa0-df6a-41e8-acb0-4e8468fc1fbc" xlink:to="loc_anab_RevenueRecognitionMilestoneMethodMaximumRevenuePerMilestone_1034ddb2-9019-4e62-929e-4ab839bc26a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CollaborativeResearchandDevelopmentAgreementsScheduleofMilestoneAchievedDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#CollaborativeResearchandDevelopmentAgreementsScheduleofMilestoneAchievedDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/CollaborativeResearchandDevelopmentAgreementsScheduleofMilestoneAchievedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_21683a97-06ae-4526-a327-0b5e62c844cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementByTypeTable_db334117-b81a-4dbd-ba0c-097d9cff0be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueArrangementByTypeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_21683a97-06ae-4526-a327-0b5e62c844cc" xlink:to="loc_us-gaap_DeferredRevenueArrangementByTypeTable_db334117-b81a-4dbd-ba0c-097d9cff0be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_7b4ffafe-374f-4cbd-91aa-86be0b5b126a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_db334117-b81a-4dbd-ba0c-097d9cff0be6" xlink:to="loc_srt_CounterpartyNameAxis_7b4ffafe-374f-4cbd-91aa-86be0b5b126a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7bf78d14-650e-45ef-b156-62e04bfc054d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_7b4ffafe-374f-4cbd-91aa-86be0b5b126a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7bf78d14-650e-45ef-b156-62e04bfc054d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_GlaxoSmithKlineMember_192f5ad8-6e39-4474-bc83-62fad023e6bb" xlink:href="anab-20220331.xsd#anab_GlaxoSmithKlineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7bf78d14-650e-45ef-b156-62e04bfc054d" xlink:to="loc_anab_GlaxoSmithKlineMember_192f5ad8-6e39-4474-bc83-62fad023e6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_722db112-4484-4e43-9c95-10fff439bdd8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_db334117-b81a-4dbd-ba0c-097d9cff0be6" xlink:to="loc_srt_ProductOrServiceAxis_722db112-4484-4e43-9c95-10fff439bdd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_47fcffb3-a338-453d-b60b-a31a4266314d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_722db112-4484-4e43-9c95-10fff439bdd8" xlink:to="loc_srt_ProductsAndServicesDomain_47fcffb3-a338-453d-b60b-a31a4266314d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AnaptysBioGeneratedAntiPD1JEMPERLIDostarlimabMember_e99264d5-6445-48ba-927f-413f3af34269" xlink:href="anab-20220331.xsd#anab_AnaptysBioGeneratedAntiPD1JEMPERLIDostarlimabMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_47fcffb3-a338-453d-b60b-a31a4266314d" xlink:to="loc_anab_AnaptysBioGeneratedAntiPD1JEMPERLIDostarlimabMember_e99264d5-6445-48ba-927f-413f3af34269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AnaptysBioGeneratedAntiTIM3GSK4069889ACobolimabMember_bed8a668-46a4-4de5-ae6b-8d34ce7f8db4" xlink:href="anab-20220331.xsd#anab_AnaptysBioGeneratedAntiTIM3GSK4069889ACobolimabMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_47fcffb3-a338-453d-b60b-a31a4266314d" xlink:to="loc_anab_AnaptysBioGeneratedAntiTIM3GSK4069889ACobolimabMember_bed8a668-46a4-4de5-ae6b-8d34ce7f8db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AnaptysBioGeneratedAntiLAG3GSK40974386Member_efaec836-06ee-4cd2-8239-b8fd97be8af3" xlink:href="anab-20220331.xsd#anab_AnaptysBioGeneratedAntiLAG3GSK40974386Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_47fcffb3-a338-453d-b60b-a31a4266314d" xlink:to="loc_anab_AnaptysBioGeneratedAntiLAG3GSK40974386Member_efaec836-06ee-4cd2-8239-b8fd97be8af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_59d0d0a3-c0a2-4a11-995e-6b78d9a22dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_db334117-b81a-4dbd-ba0c-097d9cff0be6" xlink:to="loc_us-gaap_TypeOfArrangementAxis_59d0d0a3-c0a2-4a11-995e-6b78d9a22dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1e429a53-6d86-4c7f-b66c-2739cdc77edf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_59d0d0a3-c0a2-4a11-995e-6b78d9a22dbb" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1e429a53-6d86-4c7f-b66c-2739cdc77edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_InVivoToxicologyStudiesMember_c6f4ba30-c319-461e-bf16-88c42b1c5c86" xlink:href="anab-20220331.xsd#anab_InVivoToxicologyStudiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1e429a53-6d86-4c7f-b66c-2739cdc77edf" xlink:to="loc_anab_InVivoToxicologyStudiesMember_c6f4ba30-c319-461e-bf16-88c42b1c5c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_ClearanceOfInvestigationalNewDrugFromFDAMember_bc54dfe6-4f72-4496-bc0d-81c341d60edf" xlink:href="anab-20220331.xsd#anab_ClearanceOfInvestigationalNewDrugFromFDAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1e429a53-6d86-4c7f-b66c-2739cdc77edf" xlink:to="loc_anab_ClearanceOfInvestigationalNewDrugFromFDAMember_bc54dfe6-4f72-4496-bc0d-81c341d60edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_Phase2ClinicalTrialInitiationMember_4ac94e4b-40f0-47ba-bb93-5b537080b408" xlink:href="anab-20220331.xsd#anab_Phase2ClinicalTrialInitiationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1e429a53-6d86-4c7f-b66c-2739cdc77edf" xlink:to="loc_anab_Phase2ClinicalTrialInitiationMember_4ac94e4b-40f0-47ba-bb93-5b537080b408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_Phase3ClinicalTrialInitiationFirstIndicationMember_f54352db-588b-4c40-b0c3-43085e304bd2" xlink:href="anab-20220331.xsd#anab_Phase3ClinicalTrialInitiationFirstIndicationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1e429a53-6d86-4c7f-b66c-2739cdc77edf" xlink:to="loc_anab_Phase3ClinicalTrialInitiationFirstIndicationMember_f54352db-588b-4c40-b0c3-43085e304bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_Phase3ClinicalTrialInitiationSecondIndicationMember_b7f2e633-d956-4fcd-ab1f-6d774ea6d915" xlink:href="anab-20220331.xsd#anab_Phase3ClinicalTrialInitiationSecondIndicationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1e429a53-6d86-4c7f-b66c-2739cdc77edf" xlink:to="loc_anab_Phase3ClinicalTrialInitiationSecondIndicationMember_b7f2e633-d956-4fcd-ab1f-6d774ea6d915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_FilingOfBiologicsLicenseApplicationFirstIndicationMember_657d28c5-63da-4e47-b354-255f3e29560b" xlink:href="anab-20220331.xsd#anab_FilingOfBiologicsLicenseApplicationFirstIndicationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1e429a53-6d86-4c7f-b66c-2739cdc77edf" xlink:to="loc_anab_FilingOfBiologicsLicenseApplicationFirstIndicationMember_657d28c5-63da-4e47-b354-255f3e29560b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_FilingOfMMAFirstIndicationMember_b58cb630-94c0-41d4-b55e-0ece159fc775" xlink:href="anab-20220331.xsd#anab_FilingOfMMAFirstIndicationMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1e429a53-6d86-4c7f-b66c-2739cdc77edf" xlink:to="loc_anab_FilingOfMMAFirstIndicationMember_b58cb630-94c0-41d4-b55e-0ece159fc775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_FilingOfBiologicsLicenseApplicationSecondIndicationMember_3dd13b7a-cca4-455d-95ee-0e402229b430" xlink:href="anab-20220331.xsd#anab_FilingOfBiologicsLicenseApplicationSecondIndicationMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1e429a53-6d86-4c7f-b66c-2739cdc77edf" xlink:to="loc_anab_FilingOfBiologicsLicenseApplicationSecondIndicationMember_3dd13b7a-cca4-455d-95ee-0e402229b430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_FirstBiologicsLicenseApplicationApprovalDMMRECMember_a14d283e-25af-4b03-a807-4ba34ccfd57c" xlink:href="anab-20220331.xsd#anab_FirstBiologicsLicenseApplicationApprovalDMMRECMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1e429a53-6d86-4c7f-b66c-2739cdc77edf" xlink:to="loc_anab_FirstBiologicsLicenseApplicationApprovalDMMRECMember_a14d283e-25af-4b03-a807-4ba34ccfd57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_FirstMarketingAuthorizationApplicationApprovalFirstIndicationMember_33e7eff9-c426-468b-9229-ca1ee28e9a68" xlink:href="anab-20220331.xsd#anab_FirstMarketingAuthorizationApplicationApprovalFirstIndicationMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1e429a53-6d86-4c7f-b66c-2739cdc77edf" xlink:to="loc_anab_FirstMarketingAuthorizationApplicationApprovalFirstIndicationMember_33e7eff9-c426-468b-9229-ca1ee28e9a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_FirstBiologicsLicenseApplicationApprovalSecondIndicationMember_9bfdb843-45de-4af0-a012-03d91b0ff56e" xlink:href="anab-20220331.xsd#anab_FirstBiologicsLicenseApplicationApprovalSecondIndicationMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1e429a53-6d86-4c7f-b66c-2739cdc77edf" xlink:to="loc_anab_FirstBiologicsLicenseApplicationApprovalSecondIndicationMember_9bfdb843-45de-4af0-a012-03d91b0ff56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementLineItems_8270596c-a097-493e-9bc8-840919f0a9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueArrangementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_db334117-b81a-4dbd-ba0c-097d9cff0be6" xlink:to="loc_us-gaap_DeferredRevenueArrangementLineItems_8270596c-a097-493e-9bc8-840919f0a9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ff4a7e0e-7cc6-45ed-b31c-d757070df029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_8270596c-a097-493e-9bc8-840919f0a9e6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ff4a7e0e-7cc6-45ed-b31c-d757070df029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CollaborativeResearchandDevelopmentAgreementsScheduelofFutureRevenueNotYetRecognizedDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#CollaborativeResearchandDevelopmentAgreementsScheduelofFutureRevenueNotYetRecognizedDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/CollaborativeResearchandDevelopmentAgreementsScheduelofFutureRevenueNotYetRecognizedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_7cbc6213-62d9-4834-bf07-bc1249b22017" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementByTypeTable_f575d754-49fb-4ced-bceb-f8ff2fb62ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueArrangementByTypeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_7cbc6213-62d9-4834-bf07-bc1249b22017" xlink:to="loc_us-gaap_DeferredRevenueArrangementByTypeTable_f575d754-49fb-4ced-bceb-f8ff2fb62ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_512772f2-0ae2-4e65-966e-f5d9ff65b585" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_f575d754-49fb-4ced-bceb-f8ff2fb62ad9" xlink:to="loc_srt_CounterpartyNameAxis_512772f2-0ae2-4e65-966e-f5d9ff65b585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_836dd0e9-787e-4797-9612-d40a157ff3bf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_512772f2-0ae2-4e65-966e-f5d9ff65b585" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_836dd0e9-787e-4797-9612-d40a157ff3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_GlaxoSmithKlineMember_05bb3edf-09e1-4fe0-bbd6-adf63f315d03" xlink:href="anab-20220331.xsd#anab_GlaxoSmithKlineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_836dd0e9-787e-4797-9612-d40a157ff3bf" xlink:to="loc_anab_GlaxoSmithKlineMember_05bb3edf-09e1-4fe0-bbd6-adf63f315d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_068c527e-ab59-49d6-84d2-4e80d3550ebd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_f575d754-49fb-4ced-bceb-f8ff2fb62ad9" xlink:to="loc_srt_ProductOrServiceAxis_068c527e-ab59-49d6-84d2-4e80d3550ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_220428be-6a9d-426a-8895-cf66e8ac6fc5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_068c527e-ab59-49d6-84d2-4e80d3550ebd" xlink:to="loc_srt_ProductsAndServicesDomain_220428be-6a9d-426a-8895-cf66e8ac6fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AnaptysBioGeneratedAntiPD1JEMPERLIDostarlimabMember_da7b2e75-975c-4c1d-8a5c-9a0e4f2ad584" xlink:href="anab-20220331.xsd#anab_AnaptysBioGeneratedAntiPD1JEMPERLIDostarlimabMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_220428be-6a9d-426a-8895-cf66e8ac6fc5" xlink:to="loc_anab_AnaptysBioGeneratedAntiPD1JEMPERLIDostarlimabMember_da7b2e75-975c-4c1d-8a5c-9a0e4f2ad584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AnaptysBioGeneratedAntiTIM3GSK4069889ACobolimabMember_7a164954-f1b1-4abe-b361-b4b58d4df6c7" xlink:href="anab-20220331.xsd#anab_AnaptysBioGeneratedAntiTIM3GSK4069889ACobolimabMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_220428be-6a9d-426a-8895-cf66e8ac6fc5" xlink:to="loc_anab_AnaptysBioGeneratedAntiTIM3GSK4069889ACobolimabMember_7a164954-f1b1-4abe-b361-b4b58d4df6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AnaptysBioGeneratedAntiLAG3GSK40974386Member_12ee0350-12cb-414d-8d11-2772d79b583c" xlink:href="anab-20220331.xsd#anab_AnaptysBioGeneratedAntiLAG3GSK40974386Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_220428be-6a9d-426a-8895-cf66e8ac6fc5" xlink:to="loc_anab_AnaptysBioGeneratedAntiLAG3GSK40974386Member_12ee0350-12cb-414d-8d11-2772d79b583c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_b6960d81-b018-4a7b-b256-481dff4452de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_f575d754-49fb-4ced-bceb-f8ff2fb62ad9" xlink:to="loc_us-gaap_TypeOfArrangementAxis_b6960d81-b018-4a7b-b256-481dff4452de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b45a51c2-e24a-4aed-ac21-c1bdce66e8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_b6960d81-b018-4a7b-b256-481dff4452de" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b45a51c2-e24a-4aed-ac21-c1bdce66e8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_PreClinicalAndDevelopmentMember_e280f3a8-e1a0-48f0-a12c-9062be0393d3" xlink:href="anab-20220331.xsd#anab_PreClinicalAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b45a51c2-e24a-4aed-ac21-c1bdce66e8ba" xlink:to="loc_anab_PreClinicalAndDevelopmentMember_e280f3a8-e1a0-48f0-a12c-9062be0393d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RegulatoryMember_8146b8ea-9086-4152-8731-3f594d2db268" xlink:href="anab-20220331.xsd#anab_RegulatoryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b45a51c2-e24a-4aed-ac21-c1bdce66e8ba" xlink:to="loc_anab_RegulatoryMember_8146b8ea-9086-4152-8731-3f594d2db268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_CommercialMember_01561b2e-7a44-48c9-9a7e-76a75061f82e" xlink:href="anab-20220331.xsd#anab_CommercialMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b45a51c2-e24a-4aed-ac21-c1bdce66e8ba" xlink:to="loc_anab_CommercialMember_01561b2e-7a44-48c9-9a7e-76a75061f82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementLineItems_d9de0d71-7711-4f41-bd7d-eab3eb64c82d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueArrangementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_f575d754-49fb-4ced-bceb-f8ff2fb62ad9" xlink:to="loc_us-gaap_DeferredRevenueArrangementLineItems_d9de0d71-7711-4f41-bd7d-eab3eb64c82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RevenueRecognitionMilestoneMethodContingentUponPreClinicalRegulatoryAndCommercialEvents_592ad560-e89c-4f52-9a9c-70c935be062a" xlink:href="anab-20220331.xsd#anab_RevenueRecognitionMilestoneMethodContingentUponPreClinicalRegulatoryAndCommercialEvents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_d9de0d71-7711-4f41-bd7d-eab3eb64c82d" xlink:to="loc_anab_RevenueRecognitionMilestoneMethodContingentUponPreClinicalRegulatoryAndCommercialEvents_592ad560-e89c-4f52-9a9c-70c935be062a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SaleofFutureRoyalties" xlink:type="simple" xlink:href="anab-20220331.xsd#SaleofFutureRoyalties"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/SaleofFutureRoyalties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_97509207-2ae8-4786-83b4-13c47cab39ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_SaleOfFutureRoyaltiesTextBlockTextBlock_2d7126e5-7956-48bc-a639-ad84efcff57f" xlink:href="anab-20220331.xsd#anab_SaleOfFutureRoyaltiesTextBlockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_97509207-2ae8-4786-83b4-13c47cab39ba" xlink:to="loc_anab_SaleOfFutureRoyaltiesTextBlockTextBlock_2d7126e5-7956-48bc-a639-ad84efcff57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SaleofFutureRoyaltiesTables" xlink:type="simple" xlink:href="anab-20220331.xsd#SaleofFutureRoyaltiesTables"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/SaleofFutureRoyaltiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_da03eecb-f115-47bc-a16d-c346afc1a18f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_bc9ce00a-f13c-4554-801b-f33c3e674ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_da03eecb-f115-47bc-a16d-c346afc1a18f" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_bc9ce00a-f13c-4554-801b-f33c3e674ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SaleofFutureRoyaltiesNarrativesDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#SaleofFutureRoyaltiesNarrativesDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/SaleofFutureRoyaltiesNarrativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_df8fd819-f163-4a5d-b304-b203b1a4a285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesTable_ba5cad5e-a6d8-4ec1-9bba-61a089b2cff9" xlink:href="anab-20220331.xsd#anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_df8fd819-f163-4a5d-b304-b203b1a4a285" xlink:to="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesTable_ba5cad5e-a6d8-4ec1-9bba-61a089b2cff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_83b8e787-a8f6-4882-8cbb-4860fc5a2d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesTable_ba5cad5e-a6d8-4ec1-9bba-61a089b2cff9" xlink:to="loc_us-gaap_TypeOfArrangementAxis_83b8e787-a8f6-4882-8cbb-4860fc5a2d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_054ffa00-bf9d-4ff9-b05e-be44aaf1045a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_83b8e787-a8f6-4882-8cbb-4860fc5a2d19" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_054ffa00-bf9d-4ff9-b05e-be44aaf1045a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RoyaltyPurchaseAgreementMember_335a0227-b88b-4d13-9910-4955150b7fa4" xlink:href="anab-20220331.xsd#anab_RoyaltyPurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_054ffa00-bf9d-4ff9-b05e-be44aaf1045a" xlink:to="loc_anab_RoyaltyPurchaseAgreementMember_335a0227-b88b-4d13-9910-4955150b7fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ab953543-7f90-4701-af4d-f8798d1a72ff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesTable_ba5cad5e-a6d8-4ec1-9bba-61a089b2cff9" xlink:to="loc_srt_CounterpartyNameAxis_ab953543-7f90-4701-af4d-f8798d1a72ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6adbcfc3-ab41-4aa7-a9f5-176c0f84459d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ab953543-7f90-4701-af4d-f8798d1a72ff" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6adbcfc3-ab41-4aa7-a9f5-176c0f84459d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_SagardHealthcareRoyaltyPartnersLPMember_bc18c6cd-bdc7-4e36-8f3f-d97b6088353a" xlink:href="anab-20220331.xsd#anab_SagardHealthcareRoyaltyPartnersLPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6adbcfc3-ab41-4aa7-a9f5-176c0f84459d" xlink:to="loc_anab_SagardHealthcareRoyaltyPartnersLPMember_bc18c6cd-bdc7-4e36-8f3f-d97b6088353a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AdvanceFutureRoyaltiesPaymentAxis_8d8bce63-6656-46f7-8b50-939e6cadac6b" xlink:href="anab-20220331.xsd#anab_AdvanceFutureRoyaltiesPaymentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesTable_ba5cad5e-a6d8-4ec1-9bba-61a089b2cff9" xlink:to="loc_anab_AdvanceFutureRoyaltiesPaymentAxis_8d8bce63-6656-46f7-8b50-939e6cadac6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AdvanceFutureRoyaltiesPaymentDomain_587a71b8-e034-413b-ac44-21d545bbfe5c" xlink:href="anab-20220331.xsd#anab_AdvanceFutureRoyaltiesPaymentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_AdvanceFutureRoyaltiesPaymentAxis_8d8bce63-6656-46f7-8b50-939e6cadac6b" xlink:to="loc_anab_AdvanceFutureRoyaltiesPaymentDomain_587a71b8-e034-413b-ac44-21d545bbfe5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_FirstInstallmentMember_65894294-28c3-4c86-8e02-8fc4e204c1d1" xlink:href="anab-20220331.xsd#anab_FirstInstallmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_AdvanceFutureRoyaltiesPaymentDomain_587a71b8-e034-413b-ac44-21d545bbfe5c" xlink:to="loc_anab_FirstInstallmentMember_65894294-28c3-4c86-8e02-8fc4e204c1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_SecondInstallmentMember_59f95cdb-3e47-44af-8cb8-df0c8f02257f" xlink:href="anab-20220331.xsd#anab_SecondInstallmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_AdvanceFutureRoyaltiesPaymentDomain_587a71b8-e034-413b-ac44-21d545bbfe5c" xlink:to="loc_anab_SecondInstallmentMember_59f95cdb-3e47-44af-8cb8-df0c8f02257f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_ThirdInstallmentMember_4cc39a15-6841-4e93-8c1a-158b573b097a" xlink:href="anab-20220331.xsd#anab_ThirdInstallmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_AdvanceFutureRoyaltiesPaymentDomain_587a71b8-e034-413b-ac44-21d545bbfe5c" xlink:to="loc_anab_ThirdInstallmentMember_4cc39a15-6841-4e93-8c1a-158b573b097a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesLineItems_af176583-5785-4e43-851b-e0da45ad344e" xlink:href="anab-20220331.xsd#anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesTable_ba5cad5e-a6d8-4ec1-9bba-61a089b2cff9" xlink:to="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesLineItems_af176583-5785-4e43-851b-e0da45ad344e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_ProceedsFromAdvanceFutureRoyalties_e2a93b57-e0df-4ea8-b661-2e1973c56472" xlink:href="anab-20220331.xsd#anab_ProceedsFromAdvanceFutureRoyalties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesLineItems_af176583-5785-4e43-851b-e0da45ad344e" xlink:to="loc_anab_ProceedsFromAdvanceFutureRoyalties_e2a93b57-e0df-4ea8-b661-2e1973c56472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AdvanceFutureRoyaltiesAnnualSalesThreshold_8123870b-8eff-4fab-83e1-0ee1f7543ab1" xlink:href="anab-20220331.xsd#anab_AdvanceFutureRoyaltiesAnnualSalesThreshold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesLineItems_af176583-5785-4e43-851b-e0da45ad344e" xlink:to="loc_anab_AdvanceFutureRoyaltiesAnnualSalesThreshold_8123870b-8eff-4fab-83e1-0ee1f7543ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AdvanceFutureRoyaltiesAggregatePaymentThreshold_4a0b5e26-9740-449e-909c-78373e35539f" xlink:href="anab-20220331.xsd#anab_AdvanceFutureRoyaltiesAggregatePaymentThreshold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesLineItems_af176583-5785-4e43-851b-e0da45ad344e" xlink:to="loc_anab_AdvanceFutureRoyaltiesAggregatePaymentThreshold_4a0b5e26-9740-449e-909c-78373e35539f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AdvanceFutureRoyaltiesPayments_156cc4ff-5844-4f12-a210-683c5cc69692" xlink:href="anab-20220331.xsd#anab_AdvanceFutureRoyaltiesPayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesLineItems_af176583-5785-4e43-851b-e0da45ad344e" xlink:to="loc_anab_AdvanceFutureRoyaltiesPayments_156cc4ff-5844-4f12-a210-683c5cc69692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AdvanceFutureRoyaltiesAggregatePaymentThresholdPercent_6807b69a-44cc-41be-b964-ac350bfaa774" xlink:href="anab-20220331.xsd#anab_AdvanceFutureRoyaltiesAggregatePaymentThresholdPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesLineItems_af176583-5785-4e43-851b-e0da45ad344e" xlink:to="loc_anab_AdvanceFutureRoyaltiesAggregatePaymentThresholdPercent_6807b69a-44cc-41be-b964-ac350bfaa774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AdvanceFutureRoyaltiesInternalRateOfReturn_b2a33875-6645-409a-af8e-563c06c38270" xlink:href="anab-20220331.xsd#anab_AdvanceFutureRoyaltiesInternalRateOfReturn"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesLineItems_af176583-5785-4e43-851b-e0da45ad344e" xlink:to="loc_anab_AdvanceFutureRoyaltiesInternalRateOfReturn_b2a33875-6645-409a-af8e-563c06c38270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AdvanceFutureRoyaltiesLiabilityNoncurrent_bc553317-cbde-4382-8121-803c0e9d7206" xlink:href="anab-20220331.xsd#anab_AdvanceFutureRoyaltiesLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesLineItems_af176583-5785-4e43-851b-e0da45ad344e" xlink:to="loc_anab_AdvanceFutureRoyaltiesLiabilityNoncurrent_bc553317-cbde-4382-8121-803c0e9d7206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AdvanceFutureRoyaltiesIssuanceCosts_cc7d7c44-43b6-402b-a7c6-0185bbe79dfc" xlink:href="anab-20220331.xsd#anab_AdvanceFutureRoyaltiesIssuanceCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesLineItems_af176583-5785-4e43-851b-e0da45ad344e" xlink:to="loc_anab_AdvanceFutureRoyaltiesIssuanceCosts_cc7d7c44-43b6-402b-a7c6-0185bbe79dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AdvanceFutureRoyaltiesInterestRateEffectivePercentage_0d43bceb-d3c3-44bf-b521-4f344899121f" xlink:href="anab-20220331.xsd#anab_AdvanceFutureRoyaltiesInterestRateEffectivePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesLineItems_af176583-5785-4e43-851b-e0da45ad344e" xlink:to="loc_anab_AdvanceFutureRoyaltiesInterestRateEffectivePercentage_0d43bceb-d3c3-44bf-b521-4f344899121f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_NoncashAdvanceFutureRoyaltiesRevenue_87ca86b4-29c0-4fc8-890a-2a83fb753b9d" xlink:href="anab-20220331.xsd#anab_NoncashAdvanceFutureRoyaltiesRevenue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesLineItems_af176583-5785-4e43-851b-e0da45ad344e" xlink:to="loc_anab_NoncashAdvanceFutureRoyaltiesRevenue_87ca86b4-29c0-4fc8-890a-2a83fb753b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_NoncashAdvanceFutureRoyaltiesInterestExpense_6123ebe5-fc69-4c12-a8e5-cc374425a7d5" xlink:href="anab-20220331.xsd#anab_NoncashAdvanceFutureRoyaltiesInterestExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesLineItems_af176583-5785-4e43-851b-e0da45ad344e" xlink:to="loc_anab_NoncashAdvanceFutureRoyaltiesInterestExpense_6123ebe5-fc69-4c12-a8e5-cc374425a7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SaleofFutureRoyaltiesScheduleofRoyaltyTransactionActivityDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#SaleofFutureRoyaltiesScheduleofRoyaltyTransactionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/SaleofFutureRoyaltiesScheduleofRoyaltyTransactionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_397dca7a-44b3-49a5-b8c0-cc5615cd7be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForward_8adc078f-4809-4667-b2ec-1327a8997fc7" xlink:href="anab-20220331.xsd#anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_397dca7a-44b3-49a5-b8c0-cc5615cd7be6" xlink:to="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForward_8adc078f-4809-4667-b2ec-1327a8997fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AdvanceFutureRoyaltiesLiabilities_9df9dce5-0cb7-46eb-b61a-3e581e2dd14c" xlink:href="anab-20220331.xsd#anab_AdvanceFutureRoyaltiesLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForward_8adc078f-4809-4667-b2ec-1327a8997fc7" xlink:to="loc_anab_AdvanceFutureRoyaltiesLiabilities_9df9dce5-0cb7-46eb-b61a-3e581e2dd14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AdvanceFutureRoyaltiesIssuanceCosts_28203bbc-29b3-4ef3-a934-67be74011deb" xlink:href="anab-20220331.xsd#anab_AdvanceFutureRoyaltiesIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForward_8adc078f-4809-4667-b2ec-1327a8997fc7" xlink:to="loc_anab_AdvanceFutureRoyaltiesIssuanceCosts_28203bbc-29b3-4ef3-a934-67be74011deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AmortizationOfAdvanceFutureRoyaltiesIssuanceCosts_f2c56b17-12d4-4242-9114-f72fd5d14acb" xlink:href="anab-20220331.xsd#anab_AmortizationOfAdvanceFutureRoyaltiesIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForward_8adc078f-4809-4667-b2ec-1327a8997fc7" xlink:to="loc_anab_AmortizationOfAdvanceFutureRoyaltiesIssuanceCosts_f2c56b17-12d4-4242-9114-f72fd5d14acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AdvanceFutureRoyaltiesPayments_38f38a81-1329-4937-834a-2e58b4851aaa" xlink:href="anab-20220331.xsd#anab_AdvanceFutureRoyaltiesPayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForward_8adc078f-4809-4667-b2ec-1327a8997fc7" xlink:to="loc_anab_AdvanceFutureRoyaltiesPayments_38f38a81-1329-4937-834a-2e58b4851aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_NoncashInterestExpenseRecognized_847cb8f7-98f3-43e6-af45-80914eae53c1" xlink:href="anab-20220331.xsd#anab_NoncashInterestExpenseRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForward_8adc078f-4809-4667-b2ec-1327a8997fc7" xlink:to="loc_anab_NoncashInterestExpenseRecognized_847cb8f7-98f3-43e6-af45-80914eae53c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AdvanceFutureRoyaltiesLiabilities_250e99c8-ad2e-483a-9e28-3ae0193807ea" xlink:href="anab-20220331.xsd#anab_AdvanceFutureRoyaltiesLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_anab_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForward_8adc078f-4809-4667-b2ec-1327a8997fc7" xlink:to="loc_anab_AdvanceFutureRoyaltiesLiabilities_250e99c8-ad2e-483a-9e28-3ae0193807ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestments" xlink:type="simple" xlink:href="anab-20220331.xsd#FairValueMeasurementsandAvailableforSaleInvestments"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_60ca1397-aeed-4713-9797-e9fe41ea64d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_265f2956-7cb4-4060-b773-f6023826ce80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_60ca1397-aeed-4713-9797-e9fe41ea64d3" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_265f2956-7cb4-4060-b773-f6023826ce80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsTables" xlink:type="simple" xlink:href="anab-20220331.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d61de968-7725-471b-a51d-42ba78e08538" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_eef4eb63-8548-42cc-a288-60d6a566a07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d61de968-7725-471b-a51d-42ba78e08538" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_eef4eb63-8548-42cc-a288-60d6a566a07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_b3587457-c63b-4ae3-9a88-3f34616de3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d61de968-7725-471b-a51d-42ba78e08538" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_b3587457-c63b-4ae3-9a88-3f34616de3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_914a07af-d295-41f3-a68e-de53f1aab076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d61de968-7725-471b-a51d-42ba78e08538" xlink:to="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_914a07af-d295-41f3-a68e-de53f1aab076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_495f628c-521a-434e-b4e6-607b8d86cf33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_666e57e9-909c-4da3-aa92-fed483095498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_495f628c-521a-434e-b4e6-607b8d86cf33" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_666e57e9-909c-4da3-aa92-fed483095498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f452011-fb47-4f4f-8ce1-22b5f68a8ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_666e57e9-909c-4da3-aa92-fed483095498" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f452011-fb47-4f4f-8ce1-22b5f68a8ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9f83ddbf-b146-47d5-aadd-fe1c173216ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f452011-fb47-4f4f-8ce1-22b5f68a8ffa" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9f83ddbf-b146-47d5-aadd-fe1c173216ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_8e99adcf-d005-4316-a681-5d2105ce54d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_9f83ddbf-b146-47d5-aadd-fe1c173216ee" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_8e99adcf-d005-4316-a681-5d2105ce54d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_da991452-8e47-49c7-a654-a98983a677a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_666e57e9-909c-4da3-aa92-fed483095498" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_da991452-8e47-49c7-a654-a98983a677a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84a8a556-dfb7-4057-92bd-e92ad3f8d942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_da991452-8e47-49c7-a654-a98983a677a1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84a8a556-dfb7-4057-92bd-e92ad3f8d942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_30cb3c80-0483-4b26-bc07-26fb025c44b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84a8a556-dfb7-4057-92bd-e92ad3f8d942" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_30cb3c80-0483-4b26-bc07-26fb025c44b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1bfb6786-af3f-4247-8b47-16a437a91f13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84a8a556-dfb7-4057-92bd-e92ad3f8d942" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1bfb6786-af3f-4247-8b47-16a437a91f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_f89b7635-f895-426b-84db-a75cf23aa2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84a8a556-dfb7-4057-92bd-e92ad3f8d942" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_f89b7635-f895-426b-84db-a75cf23aa2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_181783a8-8552-46d5-978d-eaf0772975ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_666e57e9-909c-4da3-aa92-fed483095498" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_181783a8-8552-46d5-978d-eaf0772975ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_f6b3b458-838c-47e3-8a7b-c11c966c8359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_181783a8-8552-46d5-978d-eaf0772975ea" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_f6b3b458-838c-47e3-8a7b-c11c966c8359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_b4845677-0bfa-400a-b3af-1841036236bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_f6b3b458-838c-47e3-8a7b-c11c966c8359" xlink:to="loc_us-gaap_MoneyMarketFundsMember_b4845677-0bfa-400a-b3af-1841036236bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_6610c3b4-ab8e-4813-b033-88ee269539c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_f6b3b458-838c-47e3-8a7b-c11c966c8359" xlink:to="loc_us-gaap_MutualFundMember_6610c3b4-ab8e-4813-b033-88ee269539c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8366ef56-b477-40bc-8621-29b017f4951d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_666e57e9-909c-4da3-aa92-fed483095498" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8366ef56-b477-40bc-8621-29b017f4951d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e46e41ff-d6ed-4251-bec6-4f42443d934b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8366ef56-b477-40bc-8621-29b017f4951d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e46e41ff-d6ed-4251-bec6-4f42443d934b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_d56a54c2-b94b-411e-bf7d-1cae7daf3659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e46e41ff-d6ed-4251-bec6-4f42443d934b" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_d56a54c2-b94b-411e-bf7d-1cae7daf3659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_61c37d81-d316-485c-b2f1-cad7ffe3e86f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e46e41ff-d6ed-4251-bec6-4f42443d934b" xlink:to="loc_us-gaap_CertificatesOfDepositMember_61c37d81-d316-485c-b2f1-cad7ffe3e86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_21e345ac-100d-4bc3-b6d9-75df13053fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e46e41ff-d6ed-4251-bec6-4f42443d934b" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_21e345ac-100d-4bc3-b6d9-75df13053fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_CommercialAndCorporateObligationsMember_36bf39b6-4f86-4c41-83b3-7ad6905eb668" xlink:href="anab-20220331.xsd#anab_CommercialAndCorporateObligationsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e46e41ff-d6ed-4251-bec6-4f42443d934b" xlink:to="loc_anab_CommercialAndCorporateObligationsMember_36bf39b6-4f86-4c41-83b3-7ad6905eb668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ffc5646-fccf-471f-8a84-ea38c11d3e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_666e57e9-909c-4da3-aa92-fed483095498" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ffc5646-fccf-471f-8a84-ea38c11d3e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_CashAndCashEquivalentsAndRestrictedCashFairValueDisclosure_12fca656-c916-4617-a6d9-6bab7b719af9" xlink:href="anab-20220331.xsd#anab_CashAndCashEquivalentsAndRestrictedCashFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ffc5646-fccf-471f-8a84-ea38c11d3e21" xlink:to="loc_anab_CashAndCashEquivalentsAndRestrictedCashFairValueDisclosure_12fca656-c916-4617-a6d9-6bab7b719af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_313b413b-6261-45e1-bf02-80ea0c8dda40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ffc5646-fccf-471f-8a84-ea38c11d3e21" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_313b413b-6261-45e1-bf02-80ea0c8dda40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAvailableforsaleInvestmentsDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsAvailableforsaleInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAvailableforsaleInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b699ab40-2625-436b-b799-ba0792b99615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_327b2dbd-a68b-40bf-ad3c-d27920a0b328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b699ab40-2625-436b-b799-ba0792b99615" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_327b2dbd-a68b-40bf-ad3c-d27920a0b328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5ec33286-0353-4879-a31a-c8e9c87ca964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_327b2dbd-a68b-40bf-ad3c-d27920a0b328" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5ec33286-0353-4879-a31a-c8e9c87ca964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f3a075fd-e76e-493f-a2cf-1ec5effdfe81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5ec33286-0353-4879-a31a-c8e9c87ca964" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f3a075fd-e76e-493f-a2cf-1ec5effdfe81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_7b64d957-faac-4793-822c-458fc436907c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f3a075fd-e76e-493f-a2cf-1ec5effdfe81" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_7b64d957-faac-4793-822c-458fc436907c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_750675ca-a16f-4e9a-9af2-20c6f9a43c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f3a075fd-e76e-493f-a2cf-1ec5effdfe81" xlink:to="loc_us-gaap_CertificatesOfDepositMember_750675ca-a16f-4e9a-9af2-20c6f9a43c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_CommercialAndCorporateObligationsMember_42ae1706-079c-4671-bac4-f7bdf7f55647" xlink:href="anab-20220331.xsd#anab_CommercialAndCorporateObligationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f3a075fd-e76e-493f-a2cf-1ec5effdfe81" xlink:to="loc_anab_CommercialAndCorporateObligationsMember_42ae1706-079c-4671-bac4-f7bdf7f55647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_7a802cf5-9631-4548-a2ab-082aaf03c3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f3a075fd-e76e-493f-a2cf-1ec5effdfe81" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_7a802cf5-9631-4548-a2ab-082aaf03c3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b7842fd7-f138-46a9-b3f1-b717b3ab40af" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_327b2dbd-a68b-40bf-ad3c-d27920a0b328" xlink:to="loc_srt_RangeAxis_b7842fd7-f138-46a9-b3f1-b717b3ab40af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c903bda8-830c-41da-b89e-7d450ffe38f3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b7842fd7-f138-46a9-b3f1-b717b3ab40af" xlink:to="loc_srt_RangeMember_c903bda8-830c-41da-b89e-7d450ffe38f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_45b34b11-3b78-4fc9-9eca-55076f3ee613" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c903bda8-830c-41da-b89e-7d450ffe38f3" xlink:to="loc_srt_MinimumMember_45b34b11-3b78-4fc9-9eca-55076f3ee613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8bb986a4-1eb4-49de-aa78-14ae8ddfd6fb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c903bda8-830c-41da-b89e-7d450ffe38f3" xlink:to="loc_srt_MaximumMember_8bb986a4-1eb4-49de-aa78-14ae8ddfd6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_363fb0fa-3315-4337-b8f7-a4e794e39af0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_327b2dbd-a68b-40bf-ad3c-d27920a0b328" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_363fb0fa-3315-4337-b8f7-a4e794e39af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_963b96b8-eeba-4986-b6e7-64d4a9ea24b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_363fb0fa-3315-4337-b8f7-a4e794e39af0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_963b96b8-eeba-4986-b6e7-64d4a9ea24b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a4b75281-00bb-40e9-a3b2-ff0f3b1dfdc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_363fb0fa-3315-4337-b8f7-a4e794e39af0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a4b75281-00bb-40e9-a3b2-ff0f3b1dfdc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8d519423-7e35-4b64-a111-b1419ff0fb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_363fb0fa-3315-4337-b8f7-a4e794e39af0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8d519423-7e35-4b64-a111-b1419ff0fb5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e68020b0-4204-4cbf-a2bc-2e486a5d3a92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_363fb0fa-3315-4337-b8f7-a4e794e39af0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e68020b0-4204-4cbf-a2bc-2e486a5d3a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c15829c6-25e9-4135-b839-9a051aa5424b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_363fb0fa-3315-4337-b8f7-a4e794e39af0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c15829c6-25e9-4135-b839-9a051aa5424b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_97f94852-010d-4dd8-8d9b-2482a8b8a3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_363fb0fa-3315-4337-b8f7-a4e794e39af0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_97f94852-010d-4dd8-8d9b-2482a8b8a3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AvailableforsaleDebtSecuritiesRemainingMaturity_a5144564-e20d-4583-b3e7-4b70dc3a75b1" xlink:href="anab-20220331.xsd#anab_AvailableforsaleDebtSecuritiesRemainingMaturity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_363fb0fa-3315-4337-b8f7-a4e794e39af0" xlink:to="loc_anab_AvailableforsaleDebtSecuritiesRemainingMaturity_a5144564-e20d-4583-b3e7-4b70dc3a75b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofUnrealizedLossandFairValuesinaLossPositionDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofUnrealizedLossandFairValuesinaLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofUnrealizedLossandFairValuesinaLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8765a02a-a56a-4332-ad8c-6efc2772b88e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6b0df4e8-5c79-4aeb-8957-4a5e3ef56db7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8765a02a-a56a-4332-ad8c-6efc2772b88e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6b0df4e8-5c79-4aeb-8957-4a5e3ef56db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ab4265d2-66e5-4e9c-bc33-40af9f3634b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6b0df4e8-5c79-4aeb-8957-4a5e3ef56db7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ab4265d2-66e5-4e9c-bc33-40af9f3634b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f71a4a54-7341-499d-b454-65d805922238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ab4265d2-66e5-4e9c-bc33-40af9f3634b3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f71a4a54-7341-499d-b454-65d805922238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_7387a57d-82c0-4276-9544-4d3d9bf35ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f71a4a54-7341-499d-b454-65d805922238" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_7387a57d-82c0-4276-9544-4d3d9bf35ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_CommercialAndCorporateObligationsMember_0e16f2cb-395f-4704-8bdf-a526a90d7953" xlink:href="anab-20220331.xsd#anab_CommercialAndCorporateObligationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f71a4a54-7341-499d-b454-65d805922238" xlink:to="loc_anab_CommercialAndCorporateObligationsMember_0e16f2cb-395f-4704-8bdf-a526a90d7953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_fb2d0cd5-fd99-4456-ba25-39b3c3a7a213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f71a4a54-7341-499d-b454-65d805922238" xlink:to="loc_us-gaap_CertificatesOfDepositMember_fb2d0cd5-fd99-4456-ba25-39b3c3a7a213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_cf723a0c-0eda-4e6c-ac35-ea3b93f737cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f71a4a54-7341-499d-b454-65d805922238" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_cf723a0c-0eda-4e6c-ac35-ea3b93f737cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d6cd1b16-4e30-43c1-b2bf-b551cf510874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6b0df4e8-5c79-4aeb-8957-4a5e3ef56db7" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d6cd1b16-4e30-43c1-b2bf-b551cf510874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_f0462387-f7f3-4f78-a815-e14e28c2751f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d6cd1b16-4e30-43c1-b2bf-b551cf510874" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_f0462387-f7f3-4f78-a815-e14e28c2751f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_988cb02d-dd82-45a8-97a5-d39a81dc16fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d6cd1b16-4e30-43c1-b2bf-b551cf510874" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_988cb02d-dd82-45a8-97a5-d39a81dc16fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_552aefbe-f56b-43ce-b9dc-09bca8ee2ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d6cd1b16-4e30-43c1-b2bf-b551cf510874" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_552aefbe-f56b-43ce-b9dc-09bca8ee2ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_9ca87096-438f-40bb-b065-b68945d176da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d6cd1b16-4e30-43c1-b2bf-b551cf510874" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_9ca87096-438f-40bb-b065-b68945d176da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_1e241897-c3f4-4194-9e21-9dd7e9b550a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d6cd1b16-4e30-43c1-b2bf-b551cf510874" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_1e241897-c3f4-4194-9e21-9dd7e9b550a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_10dcf136-0719-4eea-a0fb-45daa1b61499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d6cd1b16-4e30-43c1-b2bf-b551cf510874" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_10dcf136-0719-4eea-a0fb-45daa1b61499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsNarrativesDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsNarrativesDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsNarrativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4b66b2dd-2659-493e-b7e1-e6f2812c9b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_6c22e909-5236-4b8a-9cae-b5c0db3afd96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4b66b2dd-2659-493e-b7e1-e6f2812c9b9c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_6c22e909-5236-4b8a-9cae-b5c0db3afd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/StockholdersEquity" xlink:type="simple" xlink:href="anab-20220331.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3f3e92cb-85d0-4762-abb4-8aec7e7c8908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c5657f9c-506c-479a-b567-b0a6e2ee0d86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3f3e92cb-85d0-4762-abb4-8aec7e7c8908" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c5657f9c-506c-479a-b567-b0a6e2ee0d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="anab-20220331.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_71eed6a9-b8f5-41bb-9d05-e2e83b1534ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_b9dba0c4-f16c-4d23-aff3-80a647af54b6" xlink:href="anab-20220331.xsd#anab_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_71eed6a9-b8f5-41bb-9d05-e2e83b1534ee" xlink:to="loc_anab_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_b9dba0c4-f16c-4d23-aff3-80a647af54b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1ef67892-c1e1-4611-b762-848bfd313c35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_335bf9a3-0441-4c7a-a912-64dc3bb86dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1ef67892-c1e1-4611-b762-848bfd313c35" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_335bf9a3-0441-4c7a-a912-64dc3bb86dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_28c16782-7538-4e6b-9e5a-600dcbe3d57d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1ef67892-c1e1-4611-b762-848bfd313c35" xlink:to="loc_us-gaap_CommonStockSharesIssued_28c16782-7538-4e6b-9e5a-600dcbe3d57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_61a0cade-de86-473a-b862-3a283f315248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1ef67892-c1e1-4611-b762-848bfd313c35" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_61a0cade-de86-473a-b862-3a283f315248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_484cb692-50c4-4128-ba80-d3562c81081c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_82a12fd6-e2e2-4cb5-aa07-88baf0e25db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_484cb692-50c4-4128-ba80-d3562c81081c" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_82a12fd6-e2e2-4cb5-aa07-88baf0e25db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3f614c09-dba1-4c14-a309-4f4bdccd14b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_82a12fd6-e2e2-4cb5-aa07-88baf0e25db3" xlink:to="loc_us-gaap_PlanNameAxis_3f614c09-dba1-4c14-a309-4f4bdccd14b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b465f66a-b8f1-4b13-9ac9-47d4684e4adb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3f614c09-dba1-4c14-a309-4f4bdccd14b7" xlink:to="loc_us-gaap_PlanNameDomain_b465f66a-b8f1-4b13-9ac9-47d4684e4adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_EquityIncentivePlan2017Member_67024d9a-792e-4413-8f0c-1f014618f82b" xlink:href="anab-20220331.xsd#anab_EquityIncentivePlan2017Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b465f66a-b8f1-4b13-9ac9-47d4684e4adb" xlink:to="loc_anab_EquityIncentivePlan2017Member_67024d9a-792e-4413-8f0c-1f014618f82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_EmployeeStockPurchasePlan2017Member_0cb7362f-923e-46a0-aa64-7121d7b71860" xlink:href="anab-20220331.xsd#anab_EmployeeStockPurchasePlan2017Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b465f66a-b8f1-4b13-9ac9-47d4684e4adb" xlink:to="loc_anab_EmployeeStockPurchasePlan2017Member_0cb7362f-923e-46a0-aa64-7121d7b71860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_18a52da3-21af-4cd5-84b1-a8e71aadb29d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_82a12fd6-e2e2-4cb5-aa07-88baf0e25db3" xlink:to="loc_us-gaap_ClassOfStockLineItems_18a52da3-21af-4cd5-84b1-a8e71aadb29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_302c1b19-bc51-4008-a923-d7c717b163fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18a52da3-21af-4cd5-84b1-a8e71aadb29d" xlink:to="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_302c1b19-bc51-4008-a923-d7c717b163fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7c5dac23-b013-4582-b6c5-5ee2b7ed29b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_302c1b19-bc51-4008-a923-d7c717b163fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7c5dac23-b013-4582-b6c5-5ee2b7ed29b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_d530324e-c494-4e13-8a33-dabb48e39b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_302c1b19-bc51-4008-a923-d7c717b163fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_d530324e-c494-4e13-8a33-dabb48e39b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_13da3bf5-4185-478f-abac-7016878982d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18a52da3-21af-4cd5-84b1-a8e71aadb29d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_13da3bf5-4185-478f-abac-7016878982d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1729881d-5cc1-4cf1-b554-e2e75e0094ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18a52da3-21af-4cd5-84b1-a8e71aadb29d" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1729881d-5cc1-4cf1-b554-e2e75e0094ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/EquityIncentivePlans" xlink:type="simple" xlink:href="anab-20220331.xsd#EquityIncentivePlans"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/EquityIncentivePlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_73897ae6-bc23-49ce-b284-3b1f732d40ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_579b5a5d-260d-4efa-9e57-e81185115764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_73897ae6-bc23-49ce-b284-3b1f732d40ea" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_579b5a5d-260d-4efa-9e57-e81185115764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/EquityIncentivePlansTables" xlink:type="simple" xlink:href="anab-20220331.xsd#EquityIncentivePlansTables"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/EquityIncentivePlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c86af21d-a834-4436-96e6-b58fcab0f673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_b704ba96-efc6-4c79-bfb8-c828f669b1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c86af21d-a834-4436-96e6-b58fcab0f673" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_b704ba96-efc6-4c79-bfb8-c828f669b1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_916908cd-21e7-464e-86ac-c39d856eec53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c86af21d-a834-4436-96e6-b58fcab0f673" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_916908cd-21e7-464e-86ac-c39d856eec53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_84f161c4-6717-40ae-8690-7f8deef45963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c86af21d-a834-4436-96e6-b58fcab0f673" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_84f161c4-6717-40ae-8690-7f8deef45963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_46898a63-d078-4bde-8ff3-02c2326ae0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c86af21d-a834-4436-96e6-b58fcab0f673" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_46898a63-d078-4bde-8ff3-02c2326ae0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/EquityIncentivePlansNarrativeDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#EquityIncentivePlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/EquityIncentivePlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ae3a08d7-aa36-4b40-9520-caa52738a0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd47b1f5-cf66-40d7-ba74-e8eb3936d625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ae3a08d7-aa36-4b40-9520-caa52738a0ce" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd47b1f5-cf66-40d7-ba74-e8eb3936d625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_afb6268d-2a6b-4a9f-8f19-d37e5496e955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd47b1f5-cf66-40d7-ba74-e8eb3936d625" xlink:to="loc_us-gaap_PlanNameAxis_afb6268d-2a6b-4a9f-8f19-d37e5496e955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d4994940-92d3-4b56-b7a3-0d7352bcfb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_afb6268d-2a6b-4a9f-8f19-d37e5496e955" xlink:to="loc_us-gaap_PlanNameDomain_d4994940-92d3-4b56-b7a3-0d7352bcfb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_EquityIncentivePlan2017Member_4164dede-bc60-4080-ac5c-cf7643f9c3fd" xlink:href="anab-20220331.xsd#anab_EquityIncentivePlan2017Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d4994940-92d3-4b56-b7a3-0d7352bcfb48" xlink:to="loc_anab_EquityIncentivePlan2017Member_4164dede-bc60-4080-ac5c-cf7643f9c3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_EmployeeStockPurchasePlan2017Member_af8e0c90-8d87-4936-b8eb-c9f85f6ad59c" xlink:href="anab-20220331.xsd#anab_EmployeeStockPurchasePlan2017Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d4994940-92d3-4b56-b7a3-0d7352bcfb48" xlink:to="loc_anab_EmployeeStockPurchasePlan2017Member_af8e0c90-8d87-4936-b8eb-c9f85f6ad59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_50fc55ed-939a-41c7-8060-b85f7b85e550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd47b1f5-cf66-40d7-ba74-e8eb3936d625" xlink:to="loc_us-gaap_AwardTypeAxis_50fc55ed-939a-41c7-8060-b85f7b85e550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54b201f6-66e3-41cc-b525-3892170c499e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_50fc55ed-939a-41c7-8060-b85f7b85e550" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54b201f6-66e3-41cc-b525-3892170c499e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_3ebd2421-1d4c-4b1f-afc0-992b3b96aa41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54b201f6-66e3-41cc-b525-3892170c499e" xlink:to="loc_us-gaap_EmployeeStockMember_3ebd2421-1d4c-4b1f-afc0-992b3b96aa41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_07197fda-f399-45cc-ae82-d43d38a2adb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54b201f6-66e3-41cc-b525-3892170c499e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_07197fda-f399-45cc-ae82-d43d38a2adb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_3f6558b4-7ec2-4cc5-a7ea-e1d0b5fdf40d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54b201f6-66e3-41cc-b525-3892170c499e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_3f6558b4-7ec2-4cc5-a7ea-e1d0b5fdf40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_8cb467b2-9e51-4231-829a-b1f02541aa1b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd47b1f5-cf66-40d7-ba74-e8eb3936d625" xlink:to="loc_srt_TitleOfIndividualAxis_8cb467b2-9e51-4231-829a-b1f02541aa1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1374bece-c478-4664-a3e7-92542ca3e2f2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_8cb467b2-9e51-4231-829a-b1f02541aa1b" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1374bece-c478-4664-a3e7-92542ca3e2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_9f8bd181-d2f0-4af9-9542-51ebe99aa9a9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1374bece-c478-4664-a3e7-92542ca3e2f2" xlink:to="loc_srt_DirectorMember_9f8bd181-d2f0-4af9-9542-51ebe99aa9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_a1fa7c56-b7a1-45db-b05e-997caacde8d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1374bece-c478-4664-a3e7-92542ca3e2f2" xlink:to="loc_srt_ChiefExecutiveOfficerMember_a1fa7c56-b7a1-45db-b05e-997caacde8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_0653aaf9-aadb-4773-a769-03fd1a03902b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd47b1f5-cf66-40d7-ba74-e8eb3936d625" xlink:to="loc_srt_CounterpartyNameAxis_0653aaf9-aadb-4773-a769-03fd1a03902b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b8baad04-ff37-4cb3-a368-8e7739ff956f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_0653aaf9-aadb-4773-a769-03fd1a03902b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b8baad04-ff37-4cb3-a368-8e7739ff956f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_FormerChiefExecutiveOfficerMember_711d6208-b9c0-4a7f-a6eb-8cd12f38f9b5" xlink:href="anab-20220331.xsd#anab_FormerChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b8baad04-ff37-4cb3-a368-8e7739ff956f" xlink:to="loc_anab_FormerChiefExecutiveOfficerMember_711d6208-b9c0-4a7f-a6eb-8cd12f38f9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_InterimPresidentAndChiefExecutiveOfficerMember_d81a80e6-0af4-4e10-90e7-2feee9dd337e" xlink:href="anab-20220331.xsd#anab_InterimPresidentAndChiefExecutiveOfficerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b8baad04-ff37-4cb3-a368-8e7739ff956f" xlink:to="loc_anab_InterimPresidentAndChiefExecutiveOfficerMember_d81a80e6-0af4-4e10-90e7-2feee9dd337e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_079467b0-3836-46ef-9243-6bc4f9d947d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd47b1f5-cf66-40d7-ba74-e8eb3936d625" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_079467b0-3836-46ef-9243-6bc4f9d947d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercentOfAggregateSharesOutstanding_70ebc843-8664-45c2-b5e3-4f99ab9c2455" xlink:href="anab-20220331.xsd#anab_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercentOfAggregateSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_079467b0-3836-46ef-9243-6bc4f9d947d5" xlink:to="loc_anab_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercentOfAggregateSharesOutstanding_70ebc843-8664-45c2-b5e3-4f99ab9c2455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_CommonStockCapitalSharesReservedForFutureIssuanceIncrease_e1bd382e-65d1-48c1-bfa3-d76904f0c0c8" xlink:href="anab-20220331.xsd#anab_CommonStockCapitalSharesReservedForFutureIssuanceIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_079467b0-3836-46ef-9243-6bc4f9d947d5" xlink:to="loc_anab_CommonStockCapitalSharesReservedForFutureIssuanceIncrease_e1bd382e-65d1-48c1-bfa3-d76904f0c0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6d0ae1e3-40bd-4de0-abeb-461ecaa004b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_079467b0-3836-46ef-9243-6bc4f9d947d5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6d0ae1e3-40bd-4de0-abeb-461ecaa004b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c55fb3b7-4b6a-4724-be46-cf34ead1e36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_079467b0-3836-46ef-9243-6bc4f9d947d5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c55fb3b7-4b6a-4724-be46-cf34ead1e36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommonShareEquivalent_13345492-a1bb-4b79-ad3d-947b324b7807" xlink:href="anab-20220331.xsd#anab_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommonShareEquivalent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_079467b0-3836-46ef-9243-6bc4f9d947d5" xlink:to="loc_anab_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommonShareEquivalent_13345492-a1bb-4b79-ad3d-947b324b7807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_65a5e668-ab56-4cc7-a4e5-79c664bc0ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_079467b0-3836-46ef-9243-6bc4f9d947d5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_65a5e668-ab56-4cc7-a4e5-79c664bc0ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b4be255a-0598-4d98-bfff-9849a181a41e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_079467b0-3836-46ef-9243-6bc4f9d947d5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b4be255a-0598-4d98-bfff-9849a181a41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4791ba1a-5952-408b-96ff-b45d6f1c28f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_079467b0-3836-46ef-9243-6bc4f9d947d5" xlink:to="loc_us-gaap_ShareBasedCompensation_4791ba1a-5952-408b-96ff-b45d6f1c28f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_feb8a5dc-532e-4167-a89b-bdba7cbf6348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_079467b0-3836-46ef-9243-6bc4f9d947d5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_feb8a5dc-532e-4167-a89b-bdba7cbf6348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fc132f13-35e3-4cf0-b70e-b3cb1049addc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_079467b0-3836-46ef-9243-6bc4f9d947d5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fc132f13-35e3-4cf0-b70e-b3cb1049addc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/EquityIncentivePlansOptionActivityDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#EquityIncentivePlansOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/EquityIncentivePlansOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4ad92b36-4251-4dba-9268-20b6ede53217" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_45bb5d6d-9148-4793-817a-8d88e0f907b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4ad92b36-4251-4dba-9268-20b6ede53217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_45bb5d6d-9148-4793-817a-8d88e0f907b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b44c8420-7dee-4ab5-bcde-3f2f2c4caa4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_45bb5d6d-9148-4793-817a-8d88e0f907b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b44c8420-7dee-4ab5-bcde-3f2f2c4caa4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3b6dd177-5649-4657-8a4b-16f9b9fb8c57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_45bb5d6d-9148-4793-817a-8d88e0f907b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3b6dd177-5649-4657-8a4b-16f9b9fb8c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b19fff4f-8f80-47a2-9ae0-0208618f7b92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_45bb5d6d-9148-4793-817a-8d88e0f907b2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b19fff4f-8f80-47a2-9ae0-0208618f7b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_ec5c2b45-d6fa-48ba-91a9-aa229b4badb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_45bb5d6d-9148-4793-817a-8d88e0f907b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_ec5c2b45-d6fa-48ba-91a9-aa229b4badb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ae772ea1-9f81-4ab0-b064-db8d3f2cf053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_45bb5d6d-9148-4793-817a-8d88e0f907b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ae772ea1-9f81-4ab0-b064-db8d3f2cf053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_921f3a8c-69d6-41d5-b451-1e5a59f46adb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4ad92b36-4251-4dba-9268-20b6ede53217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_921f3a8c-69d6-41d5-b451-1e5a59f46adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e580dfdb-ee68-4726-b3d8-fc287897c339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4ad92b36-4251-4dba-9268-20b6ede53217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e580dfdb-ee68-4726-b3d8-fc287897c339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_16885bb8-d51d-47aa-a608-4c798a90c990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e580dfdb-ee68-4726-b3d8-fc287897c339" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_16885bb8-d51d-47aa-a608-4c798a90c990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_54cf27a0-6837-48e6-91f5-830e82b75b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e580dfdb-ee68-4726-b3d8-fc287897c339" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_54cf27a0-6837-48e6-91f5-830e82b75b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a2d40517-2ec9-45fe-b7bd-bd54a02ee7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e580dfdb-ee68-4726-b3d8-fc287897c339" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a2d40517-2ec9-45fe-b7bd-bd54a02ee7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_54a320a4-3b50-4c4b-b679-02ab475aa1af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e580dfdb-ee68-4726-b3d8-fc287897c339" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_54a320a4-3b50-4c4b-b679-02ab475aa1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_422cfabe-42c7-43b7-9757-41afcd16df09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e580dfdb-ee68-4726-b3d8-fc287897c339" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_422cfabe-42c7-43b7-9757-41afcd16df09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d2db87b7-cd8b-4093-b5b0-7b0e9dfb487f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4ad92b36-4251-4dba-9268-20b6ede53217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d2db87b7-cd8b-4093-b5b0-7b0e9dfb487f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b48804e8-b039-4f5a-a74e-1fa9dcadd93f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4ad92b36-4251-4dba-9268-20b6ede53217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b48804e8-b039-4f5a-a74e-1fa9dcadd93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5be6275c-f299-4680-80ca-182aef4914e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b48804e8-b039-4f5a-a74e-1fa9dcadd93f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5be6275c-f299-4680-80ca-182aef4914e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_811b6f38-99e4-4a43-9897-7f6bf35a66e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b48804e8-b039-4f5a-a74e-1fa9dcadd93f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_811b6f38-99e4-4a43-9897-7f6bf35a66e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1103c851-d15d-4e51-87b8-335ade11a093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b48804e8-b039-4f5a-a74e-1fa9dcadd93f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1103c851-d15d-4e51-87b8-335ade11a093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_d699d1c3-c281-4703-983c-5a001d1e0133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b48804e8-b039-4f5a-a74e-1fa9dcadd93f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_d699d1c3-c281-4703-983c-5a001d1e0133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/EquityIncentivePlansTimebasedRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#EquityIncentivePlansTimebasedRestrictedStockUnitsDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/EquityIncentivePlansTimebasedRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9965bd81-eb57-4a34-9f53-6edfd4b5fc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1e48c5e3-526c-44af-a676-33062cf8e949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9965bd81-eb57-4a34-9f53-6edfd4b5fc6f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1e48c5e3-526c-44af-a676-33062cf8e949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f82854a9-28cc-45a0-9834-3a18e12eab99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1e48c5e3-526c-44af-a676-33062cf8e949" xlink:to="loc_us-gaap_AwardTypeAxis_f82854a9-28cc-45a0-9834-3a18e12eab99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04d67fd8-f42d-4518-8c04-6cd95802b78a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f82854a9-28cc-45a0-9834-3a18e12eab99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04d67fd8-f42d-4518-8c04-6cd95802b78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c73f807c-0d18-4c3b-b9bd-63d74db215e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04d67fd8-f42d-4518-8c04-6cd95802b78a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c73f807c-0d18-4c3b-b9bd-63d74db215e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ff85e95-2e61-4fe2-807a-ef9177116e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1e48c5e3-526c-44af-a676-33062cf8e949" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ff85e95-2e61-4fe2-807a-ef9177116e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f68407a1-44aa-4bd2-9d41-a4de5d97172c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ff85e95-2e61-4fe2-807a-ef9177116e88" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f68407a1-44aa-4bd2-9d41-a4de5d97172c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c3dbdc5a-61ab-49ae-859f-a734d2b80f65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f68407a1-44aa-4bd2-9d41-a4de5d97172c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c3dbdc5a-61ab-49ae-859f-a734d2b80f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a6a1f1fb-62fe-46e5-8611-c9cae27a9281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f68407a1-44aa-4bd2-9d41-a4de5d97172c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a6a1f1fb-62fe-46e5-8611-c9cae27a9281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1ab4eccb-aed8-477f-abf6-03389f232228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f68407a1-44aa-4bd2-9d41-a4de5d97172c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1ab4eccb-aed8-477f-abf6-03389f232228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c6ea0b87-2d40-4cff-b1d0-1a88047ee63c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f68407a1-44aa-4bd2-9d41-a4de5d97172c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c6ea0b87-2d40-4cff-b1d0-1a88047ee63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_142ad41a-c84b-4610-a37c-6617fef19629" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f68407a1-44aa-4bd2-9d41-a4de5d97172c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_142ad41a-c84b-4610-a37c-6617fef19629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingNumber_c27d1ced-7503-4d7b-8651-bff08c2d1761" xlink:href="anab-20220331.xsd#anab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ff85e95-2e61-4fe2-807a-ef9177116e88" xlink:to="loc_anab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingNumber_c27d1ced-7503-4d7b-8651-bff08c2d1761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_45777c6e-498b-4548-8578-340290df0293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ff85e95-2e61-4fe2-807a-ef9177116e88" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_45777c6e-498b-4548-8578-340290df0293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_49a616f5-4535-47d8-bf7c-7d02e2c1ce92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_45777c6e-498b-4548-8578-340290df0293" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_49a616f5-4535-47d8-bf7c-7d02e2c1ce92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_994cb2a4-c4c4-482f-ba11-910835be45b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_45777c6e-498b-4548-8578-340290df0293" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_994cb2a4-c4c4-482f-ba11-910835be45b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1487568c-a81a-419c-9e09-a63eb9578242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_45777c6e-498b-4548-8578-340290df0293" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1487568c-a81a-419c-9e09-a63eb9578242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fea10a55-a293-4d9c-8b16-c6cbe80b96d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_45777c6e-498b-4548-8578-340290df0293" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fea10a55-a293-4d9c-8b16-c6cbe80b96d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3d4a6a3d-4d5d-4efe-a3e9-b1b70c266b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_45777c6e-498b-4548-8578-340290df0293" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3d4a6a3d-4d5d-4efe-a3e9-b1b70c266b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_e26a8850-3b5d-4dc4-958c-8e38b1dbcf1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ff85e95-2e61-4fe2-807a-ef9177116e88" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_e26a8850-3b5d-4dc4-958c-8e38b1dbcf1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_dfec184a-b49b-4da4-a20e-bf3201016d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_e26a8850-3b5d-4dc4-958c-8e38b1dbcf1e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_dfec184a-b49b-4da4-a20e-bf3201016d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_9a09dd73-7f52-41de-affc-94dae6215c32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_e26a8850-3b5d-4dc4-958c-8e38b1dbcf1e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_9a09dd73-7f52-41de-affc-94dae6215c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_ddf86ac0-33c8-4ca8-9c07-9ebdedc97e22" xlink:href="anab-20220331.xsd#anab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ff85e95-2e61-4fe2-807a-ef9177116e88" xlink:to="loc_anab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_ddf86ac0-33c8-4ca8-9c07-9ebdedc97e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/EquityIncentivePlansSummaryofWeightedAverageAssumptionsusedtoEstimateFairValueDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#EquityIncentivePlansSummaryofWeightedAverageAssumptionsusedtoEstimateFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/EquityIncentivePlansSummaryofWeightedAverageAssumptionsusedtoEstimateFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cf37fcaa-c04e-4c29-b218-b9828a7489df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2eae5e1c-860b-4ec4-b59d-96a072a6aa50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cf37fcaa-c04e-4c29-b218-b9828a7489df" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2eae5e1c-860b-4ec4-b59d-96a072a6aa50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ec3a8da7-a937-4944-9f4c-4ee15d7e87be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2eae5e1c-860b-4ec4-b59d-96a072a6aa50" xlink:to="loc_us-gaap_AwardTypeAxis_ec3a8da7-a937-4944-9f4c-4ee15d7e87be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5006be22-14e2-4bd5-8b60-dd3a4c40445b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ec3a8da7-a937-4944-9f4c-4ee15d7e87be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5006be22-14e2-4bd5-8b60-dd3a4c40445b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6af239c4-53b2-4e8c-be25-dd8a25a8d62d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5006be22-14e2-4bd5-8b60-dd3a4c40445b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6af239c4-53b2-4e8c-be25-dd8a25a8d62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f77c3981-1911-48d5-bbce-e3533a44282d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2eae5e1c-860b-4ec4-b59d-96a072a6aa50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f77c3981-1911-48d5-bbce-e3533a44282d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_e2431bd4-2fcb-426f-8bdb-03b33b00b1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f77c3981-1911-48d5-bbce-e3533a44282d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_e2431bd4-2fcb-426f-8bdb-03b33b00b1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_4867e8d2-06d7-4d7c-90c6-244a4995720c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f77c3981-1911-48d5-bbce-e3533a44282d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_4867e8d2-06d7-4d7c-90c6-244a4995720c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ffd61de3-899f-491b-bb53-be4c8e8530de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f77c3981-1911-48d5-bbce-e3533a44282d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ffd61de3-899f-491b-bb53-be4c8e8530de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_cb2c5669-96b6-4519-b68d-89b0b952c67b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f77c3981-1911-48d5-bbce-e3533a44282d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_cb2c5669-96b6-4519-b68d-89b0b952c67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f585e439-90b3-4e37-99bc-2cadb823e4b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f77c3981-1911-48d5-bbce-e3533a44282d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f585e439-90b3-4e37-99bc-2cadb823e4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/EquityIncentivePlansAllocationofSharebasedCompensationExpenseDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#EquityIncentivePlansAllocationofSharebasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/EquityIncentivePlansAllocationofSharebasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_69248c21-3e39-46fa-8366-94129a4c5286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2fc821a9-c639-4623-be5e-b99857d68b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_69248c21-3e39-46fa-8366-94129a4c5286" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2fc821a9-c639-4623-be5e-b99857d68b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fd5ac72b-d131-4114-a3e5-c5596319983a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2fc821a9-c639-4623-be5e-b99857d68b9d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fd5ac72b-d131-4114-a3e5-c5596319983a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_832d8301-a0ff-43b3-9044-a2515db87bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fd5ac72b-d131-4114-a3e5-c5596319983a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_832d8301-a0ff-43b3-9044-a2515db87bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_95ca24b2-f1d0-443f-95cb-7c632d9f89f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_832d8301-a0ff-43b3-9044-a2515db87bfa" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_95ca24b2-f1d0-443f-95cb-7c632d9f89f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_d323e2f7-5c88-49cc-9393-66493b0381cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_832d8301-a0ff-43b3-9044-a2515db87bfa" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_d323e2f7-5c88-49cc-9393-66493b0381cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1ec5f1a5-32a1-4403-b0a6-c91377513767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2fc821a9-c639-4623-be5e-b99857d68b9d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1ec5f1a5-32a1-4403-b0a6-c91377513767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_7c1cf704-8233-4ec4-8646-3d8f414991a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1ec5f1a5-32a1-4403-b0a6-c91377513767" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_7c1cf704-8233-4ec4-8646-3d8f414991a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="anab-20220331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_25bd54c1-e709-4697-87ae-6b34440d00cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_76aa971b-2e9c-4c56-9a4d-70e124474507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_25bd54c1-e709-4697-87ae-6b34440d00cf" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_76aa971b-2e9c-4c56-9a4d-70e124474507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="anab-20220331.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f4d524e-097c-44f2-b612-f6a116d8c442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_192890f6-ddc6-4efb-9627-5f7845d686e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f4d524e-097c-44f2-b612-f6a116d8c442" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_192890f6-ddc6-4efb-9627-5f7845d686e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_603137ef-6866-43b2-b738-5aa0c9eab26a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f4d524e-097c-44f2-b612-f6a116d8c442" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_603137ef-6866-43b2-b738-5aa0c9eab26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#CommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_350769ef-f614-410a-a222-22ac27ee5db5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_81d820a1-9576-456a-ac05-fdd4cb12452d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_350769ef-f614-410a-a222-22ac27ee5db5" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_81d820a1-9576-456a-ac05-fdd4cb12452d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_897d3912-2407-48d8-b06c-8c36e2a1ee78" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_81d820a1-9576-456a-ac05-fdd4cb12452d" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_897d3912-2407-48d8-b06c-8c36e2a1ee78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_8c5464f8-c94b-44fd-a4e1-baf58e70fdbe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_897d3912-2407-48d8-b06c-8c36e2a1ee78" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_8c5464f8-c94b-44fd-a4e1-baf58e70fdbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_A10770WateridgeCircleSanDiegoCalifornia92121Member_d0b985a3-86d3-47ba-b81c-f723fc619dc9" xlink:href="anab-20220331.xsd#anab_A10770WateridgeCircleSanDiegoCalifornia92121Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_8c5464f8-c94b-44fd-a4e1-baf58e70fdbe" xlink:to="loc_anab_A10770WateridgeCircleSanDiegoCalifornia92121Member_d0b985a3-86d3-47ba-b81c-f723fc619dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_faecf39f-d8ed-438c-bbfb-d17bc9628dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_81d820a1-9576-456a-ac05-fdd4cb12452d" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_faecf39f-d8ed-438c-bbfb-d17bc9628dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_2cce014b-6572-4700-a4db-810840bd9e77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_faecf39f-d8ed-438c-bbfb-d17bc9628dd0" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_2cce014b-6572-4700-a4db-810840bd9e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_3f8b3ec4-0b99-4248-93ef-5255fcf37f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_faecf39f-d8ed-438c-bbfb-d17bc9628dd0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_3f8b3ec4-0b99-4248-93ef-5255fcf37f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1_68168dbd-9c29-4838-8c62-9f218c561aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_faecf39f-d8ed-438c-bbfb-d17bc9628dd0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1_68168dbd-9c29-4838-8c62-9f218c561aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_LesseeOperatingLeaseLeaseNotyetCommencedExpirationPeriod_8a541a06-1ab3-4c8e-8568-2d7be64ea99f" xlink:href="anab-20220331.xsd#anab_LesseeOperatingLeaseLeaseNotyetCommencedExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_faecf39f-d8ed-438c-bbfb-d17bc9628dd0" xlink:to="loc_anab_LesseeOperatingLeaseLeaseNotyetCommencedExpirationPeriod_8a541a06-1ab3-4c8e-8568-2d7be64ea99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_RentPerSquareFoot_2e22623d-9ef5-4634-950d-e5c54793f3cb" xlink:href="anab-20220331.xsd#anab_RentPerSquareFoot"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_faecf39f-d8ed-438c-bbfb-d17bc9628dd0" xlink:to="loc_anab_RentPerSquareFoot_2e22623d-9ef5-4634-950d-e5c54793f3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AnnualRentIncreasePercent_45be3511-4270-400f-b924-76e8242a4e2d" xlink:href="anab-20220331.xsd#anab_AnnualRentIncreasePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_faecf39f-d8ed-438c-bbfb-d17bc9628dd0" xlink:to="loc_anab_AnnualRentIncreasePercent_45be3511-4270-400f-b924-76e8242a4e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_22f5fa83-bdd2-41c0-88d4-40f81b0a6b68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_faecf39f-d8ed-438c-bbfb-d17bc9628dd0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_22f5fa83-bdd2-41c0-88d4-40f81b0a6b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ae9dccb5-d7d4-43f5-a98a-0f56e2a40390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_faecf39f-d8ed-438c-bbfb-d17bc9628dd0" xlink:to="loc_us-gaap_OperatingLeaseLiability_ae9dccb5-d7d4-43f5-a98a-0f56e2a40390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecurityDeposit_f9099ce9-ed66-47fb-94b5-624bfe15c0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_faecf39f-d8ed-438c-bbfb-d17bc9628dd0" xlink:to="loc_us-gaap_SecurityDeposit_f9099ce9-ed66-47fb-94b5-624bfe15c0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_212f0989-0e68-4beb-9d13-e22244286170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_faecf39f-d8ed-438c-bbfb-d17bc9628dd0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_212f0989-0e68-4beb-9d13-e22244286170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7ef1e6f5-a54e-4acb-89d5-bb56993eb9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_faecf39f-d8ed-438c-bbfb-d17bc9628dd0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7ef1e6f5-a54e-4acb-89d5-bb56993eb9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CommitmentsandContingenciesCostsIncludedinCashFlowStatementDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#CommitmentsandContingenciesCostsIncludedinCashFlowStatementDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/CommitmentsandContingenciesCostsIncludedinCashFlowStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_681b949f-279b-4b5e-b5fb-9d90a0a9bc02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_f7034195-18da-4eef-bc81-b669bcce54b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_681b949f-279b-4b5e-b5fb-9d90a0a9bc02" xlink:to="loc_us-gaap_OperatingLeaseCost_f7034195-18da-4eef-bc81-b669bcce54b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_788d9471-47b6-4707-a172-163e2087a7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_681b949f-279b-4b5e-b5fb-9d90a0a9bc02" xlink:to="loc_us-gaap_OperatingLeasePayments_788d9471-47b6-4707-a172-163e2087a7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CommitmentsandContingenciesScheduleofFutureMinimumAnnualObligationsDetails" xlink:type="simple" xlink:href="anab-20220331.xsd#CommitmentsandContingenciesScheduleofFutureMinimumAnnualObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/CommitmentsandContingenciesScheduleofFutureMinimumAnnualObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bbb1aaa6-86ae-4c15-9753-a420450b42be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_f4726f5a-7edd-47c1-8639-f096b05c9bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bbb1aaa6-86ae-4c15-9753-a420450b42be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_f4726f5a-7edd-47c1-8639-f096b05c9bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e27330e0-bfef-49a0-8df1-c2f323ef18d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bbb1aaa6-86ae-4c15-9753-a420450b42be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e27330e0-bfef-49a0-8df1-c2f323ef18d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_38bd3748-34ed-401e-adba-f15a8ed253b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bbb1aaa6-86ae-4c15-9753-a420450b42be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_38bd3748-34ed-401e-adba-f15a8ed253b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_691b3ee3-4f7b-448b-ad9c-71e0d51f1155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bbb1aaa6-86ae-4c15-9753-a420450b42be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_691b3ee3-4f7b-448b-ad9c-71e0d51f1155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6ac2b048-9555-4028-b8ee-b51db3460324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bbb1aaa6-86ae-4c15-9753-a420450b42be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6ac2b048-9555-4028-b8ee-b51db3460324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_40d97bfb-588f-47d7-9aba-01c0906929bc" xlink:href="anab-20220331.xsd#anab_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bbb1aaa6-86ae-4c15-9753-a420450b42be" xlink:to="loc_anab_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_40d97bfb-588f-47d7-9aba-01c0906929bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4b24c4d7-c357-46ab-9747-175ba06a888f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bbb1aaa6-86ae-4c15-9753-a420450b42be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4b24c4d7-c357-46ab-9747-175ba06a888f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5690da38-510a-47d3-8722-a45a8364e55e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bbb1aaa6-86ae-4c15-9753-a420450b42be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5690da38-510a-47d3-8722-a45a8364e55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0f24f55e-cab2-4d0e-92a2-f3fc2d3b5d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bbb1aaa6-86ae-4c15-9753-a420450b42be" xlink:to="loc_us-gaap_OperatingLeaseLiability_0f24f55e-cab2-4d0e-92a2-f3fc2d3b5d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CommitmentsandContingenciesScheduleofFutureMinimumAnnualObligationsDetails_1" xlink:type="simple" xlink:href="anab-20220331.xsd#CommitmentsandContingenciesScheduleofFutureMinimumAnnualObligationsDetails_1"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/CommitmentsandContingenciesScheduleofFutureMinimumAnnualObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SubsequentEvent" xlink:type="simple" xlink:href="anab-20220331.xsd#SubsequentEvent"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/SubsequentEvent" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_d04fcbaf-44d4-4cfe-8b33-780bbc7b4b46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_879175cf-b51a-4b36-afa6-62688833aa10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_d04fcbaf-44d4-4cfe-8b33-780bbc7b4b46" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_879175cf-b51a-4b36-afa6-62688833aa10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
